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Measurement of metabolism in single cells holds the potential to advance our 
understanding of fundamental biological processes during cell differentiation and 
development. However, to characterize the metabolic state of single cells, further 
technological advances are still required. This dissertation discusses the development 
and application of single-cell mass spectrometry (MS) technologies to investigate 
metabolism and its role during tissue induction in the early developing vertebrate 
(frog) embryo. The work presented herein illustrates the strategies devised to advance 
single-cell analysis using capillary electrophoresis (CE)-MS. Additionally, this work 
features several contributions to our understanding of cell heterogeneity and the role 
of small molecules during tissue specification in the vertebrate embryo, providing 
new information to advance cell and developmental biology. 
  
 Chapter 1 overviews the current state of metabolomics for cell and 
developmental biology, as well as the research significance and motivations. 
 Chapter 2 describes the fundamental concepts of CE and the current state of 
single-cell metabolomics by CE-MS. This chapter also discusses the development of 
a minimally invasive microprobe sampling technique designed for the Xenopus laevis 
embryo. 
 Chapter 3 presents the development of a CE-MS approach that enables dual 
cationic and anionic analysis of metabolites from the same single embryonic cell to 
deepen the detectable coverage of metabolism. 
 Chapter 4 discusses a stable-isotope labeling strategy and single-cell CE-MS 
to uncover metabolic pathways involved in cell differentiation.  
Chapter 5 details the application of our custom-built microprobe sampling 
technique to investigate spatial cell heterogeneity in the same vertebrate embryo. This 
chapter examines cell-to-cell communication and small molecule transport between 
adjacent cells. Moreover, dual-fluorescent cell lineage tracing reveals cell fate 
changes induced by small molecule transport. 
Chapter 6 summarizes the results generated from this dissertation work and 
reflects on technical challenges and potential advancements needed to drive the field 
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Chapter 1: Introduction   
1.1 Single-cell multi-omics  
 
Detection of all the molecules (multi-omics) in single cells promises to revolutionize 
our understanding of complex biochemical events in the cell. A cell’s state is affected 
by downstream processes of its genome, transcriptome, proteome, and metabolome, 
thus yielding a vast molecular complexity that is yet to be uncovered. For instance, 
the human genome contains ~20,300 protein-coding genes,1 which produce ~20,000 
proteins spanning a 7–10 log-order concentration range.2 The Human Metabolome 
Database3 currently reports ~114,200 small molecules with concentrations covering a 
similar broad dynamic range, which corresponds to only a small fraction of the total 
metabolites present in the cell.  With the technological advances developed in the last 
decade, genome-scale molecular information at the resolution of single cells has 
yielded unprecedented power for systematic investigation of cellular heterogeneity in 
DNA,4-6 RNA,7-8 proteins,9-11 and metabolites.12-14  
Single-cell sequencing technologies recently enabled the direct sequencing of 
DNA and RNA under the same experimental conditions generating an unbiased 
readout of the cell’s genotype and phenotype. For example, using parallel DNA-
mRNA (or DR-seq),15 the DNA and mRNA material of single mouse embryonic stem 
cells was amplified without physically separating the nucleic acids before 
amplification, yielding lower sample losses. The application of DR-seq also detected 






variations may drive variability in gene expression among individual cells. 
Additionally, advances in single-cell transcriptomics using microfluidic devices7, 16 
have improved measurement throughput by enabling the barcoding and detection of 
4,000–12,000 individual cells per hour. Although the genome and transcriptome of a 
cell captures valuable information regarding the cell’s state, much of the function of 
the cell is determined by their downstream products.17  
The single-cell proteome and metabolome provide complementary 
information into the cell’s molecular state. Characterization of the cell’s proteome 
and metabolome promises to deepen our understanding of cellular behaviors and 
phenotypic identities.18 However, without molecular amplification of the entire 
proteome and metabolome, it has been technologically challenging to characterize 
molecular events downstream of gene transcription with adequate molecular 
coverage, sensitivity, or scalability. Currently, mass spectrometry (MS) is the 
technology of choice for the detection of proteins in single cells. By developing a 
custom-built capillary electrophoresis (CE)- electrospray ionization (ESI) platform, 
the Nemes lab was able to detect and quantify ~600–800 protein groups from ~5 ng 
of total protein content in live embryonic cells.9, 19 Additionally, single-cell 
proteomics by MS (SCoPE-MS)20 was able to achieve adequate ion signal for peptide 
sequencing and quantification in mammalian cells by combining isobaric tandem 
mass tags (TMT)21 and “single-cell augmented samples” comprised of ~200 carrier 
cells. Overall, single-cell proteomics technologies coupled to separation-based 






have enabled the analysis of protein production in single eggs,9-10, 19 small tissues,22 
and small populations of cells23 isolated from frog or human24 embryos.  
The metabolome is viewed as the ultimate descriptor of a cell’s molecular 
phenotype. The metabolome amasses downstream products of intrinsic events, such 
as transcription, translation, and changing phases of the cell cycle, as well as extrinsic 
influences, including chemical, physical, and biological cues. Therefore, the single-
cell metabolome provides a sensitive and effective descriptor of the cell's molecular 
state. Emerging single-cell MS technologies have facilitated the analysis of 
metabolites in a neuron,14, 25 whole embryos,13, 26 tissues,27 and single-cells.12, 28-31 
However, single-cell metabolomic MS methods are faced with several analytical 
challenges. For example, the metabolome encompasses an extensive number of 
metabolites with rapid turnover rates (milliseconds–seconds), a broad concentration 
range, and diverse physiochemical properties. Therefore, at present there is no single 
approach amenable to characterize the entire suite of metabolites in the cell. Yet, 
single-cell metabolomics raises the potential to identify cell-to-cell expression 
signatures during normal or pathological processes, such as during embryogenesis. 
For example, small biomolecules such as folic acid,32 coenzyme A (CoA),33 and 
amino acids12 (e.g., methionine, threonine) have been recently identified to mediate 
essential metabolic pathways/metabolism that regulate embryogenesis in the 
vertebrate Xenopus laevis embryo.  
In what follows, I discuss the applications of MS and metabolomics for cell 
and developmental biology to put in perspective the work presented in this 






of metabolites in embryonic models, including the South African clawed frog 
(Xenopus laevis), which is the animal model used in this work. Finally, the scientific 
significance and motivations behind the present dissertation work are discussed. 
1.2 Metabolite analysis for cell and developmental biology  
 
1.2.1 Metabolomics by mass spectrometry  
Mass spectrometry (MS) is the analytical technology of choice for detecting 
and quantifying metabolites due to its high sensitivity, specificity, and label-free 
detection. MS-based metabolomics workflows can be streamlined to deliver high 
reproducibility (e.g., quantitative error <5% relative standard deviation),12 allowing 
for both absolute and relative quantification. Currently, two complementary 
approaches are used for the analysis of metabolites by MS: metabolite profiling (or 
targeted) and discovery (or untargeted) analysis. Metabolic profiling targets a 
subgroup of metabolites, which are typically related to a specific metabolic pathway. 
Therefore, targeted metabolomics-MS approaches are effective and routinely utilized 
in the discovery of therapeutic and toxicant (pollutant) biomarkers.34 On the other 
hand, a discovery or untargeted metabolic analysis aims to compare metabolite 
composition between samples by measuring as many metabolites as possible. In 
general, single-cell metabolomics (targeted or untargeted) follows rigorous 
experimental design to ensure high-quality results. Key steps of the workflow include 
cell identification, isolation, detection, metabolite identification, quantification, and 
data interpretation (see Figure 1.1). Specific considerations for single-cell 







Figure 1.1 General MS-based metabolomics workflow for the detection of 
metabolites in biological samples. Adapted with permission from ref. 53. 
 
To facilitate the analysis of different types of metabolites in biological 
samples, it is advisable to couple MS with a chemical-based separation method, such 
as gas chromatography (GC), LC, and CE. For example, the advantages of using GC-
MS include high separation efficiency and reproducible retention times. However, a 
notable disadvantage of metabolomic analysis with GC-MS is the need to perform 
chemical derivatization (e.g., silylation35) to analyze polar metabolites, which limits 
molecular coverage. For LC-MS, a variety of methods have been developed based on 






routinely utilized in the analysis of metabolites36-37 and lipids.38 Additionally, 
hydrophilic interaction chromatography (HILIC) methods39-40 are preferentially used 
in the analysis of polar metabolites. Moreover, CE-MS is an emerging technology 
able to achieve high separation efficiency of metabolites from low-volume samples.41 
Another key aspect to consider when conducting metabolomics experiments is 
metabolite identification. A major challenge for the identification of metabolites 
using MS is that a single mass-to-charge ratio (m/z) value can yield hundreds of 
possible chemical compound matches. To address this concern, a set of minimum 
requirements for reporting chemical analysis and metabolite identifications in 
metabolomic studies has been recently suggested, known as the Metabolomics 
Standards Initiative (MSI).42 Moreover, by combining chemical-based separation 
technologies, higher resolution mass spectrometers, smart “mass analysis” 
algorithms, and comprehensive databases (e.g., Metlin,43 Human Metabolome 
Database,3 mzCloud (https://www.mzcloud.org/), etc.), it is now possible to 
confidently and rapidly identify numerous metabolites via MS.     
1.2.2 Metabolomics for cell and developmental biology 
Recent mass spectrometry technologies have enabled the detection of 
hundreds of metabolites and lipids in vertebrate embryonic models, facilitating the 
assessment of spatial and temporal metabolic and lipidomic changes during 
embryonic development. For example, ambient ionization techniques44-45 coupled to 
MS are capable of detecting metabolites and lipids in mouse,46 bovine,47 porcine,48 






rapid analysis times. Chemical characterization of metabolites and lipids from mouse 
(Figure 1.2A) and bovine embryos using desorption electrospray ionization (DESI)-
MS46-47 resulted in a detailed annotation of metabolic and lipid profiles from oocytes 
and blastocysts. Additionally, metabolites and lipids from X. laevis frog embryos 
were characterized using laser ablation electrospray ionization (LAESI)-MS50 (Figure 
1.2B), which uncovered heterogeneity across the animal–vegetal axis. A total of 52 
metabolites including amino acids and ~90 lipids were putatively identified and 
compared between the animal–vegetal poles. Recently, nanostructure initiator MS 
(NIMS)51 enabled the detection of several metabolites and lipids in the mouse embryo  
(Figure 1.2C). By utilizing tightly focused beams of electrons, monoatomic, or 
polyatomic ions (e.g., C+60 or Au+3) to sputter metabolites with 10–100 nm resolution, 
time-of-flight secondary ionization MS (TOF-SIMS)52 uncovered heterogeneous lipid 
distribution in zygotes and embryos of X. laevis (Figure 1.2D). The high-resolution 
molecular images captured by TOF-SIMS show potential egg-sperm lipid fusion sites 
and reorganization of the membrane in the cleavage-stage embryo.53 Laser-based 
ionization techniques provide information on the metabolic and lipid composition of a 
thin section and/or surface of the embryo. 
Other analytical techniques have focused on the analysis of metabolites from 
whole embryos,13 tissues,54 and single-cells12, 30-31, 55-56 to deepen the coverage of the 
metabolome. For example, liquid chromatography (LC) was employed as a separation 
step coupled with detection by MS to identify metabolites among pooled samples of 
whole X. laevis embryos collected at different developmental stages.13 Furthermore, 






as the citric acid (Krebbs or TCA) cycle, suggested that alanine and aspartate pools 
serve as energy sources of the developing embryo. 
 
Figure 1.2 Metabolite imaging in developing embryos. (A) Desorption electrospray 
ionization (DESI). (B) Laser ablation electrospray ionization (LAESI). (C) 
Nanostructure-initiator MS (NIMS). (D) Time-of-Flight secondary ion MS. Adapted 
with permission from refs. 50 and 53. 
 
CE offers several advantages for single-cell MS analysis. First, CE is 
amenable to small sample volumes (<1 nL), which are commonly encountered in 
single cells. It provides a higher number of theoretical plates as compared to partition 
chromatography (e.g., LC). Better resolution in separation is important because it 
enables the separation of metabolites from a complex biological sample. Finally, as a 
separation step prior to ionization and detection by MS, it provides a unique 
migration time value for each detected compound, becoming a useful tool for the 






platform, our lab investigated metabolic heterogeneity among cells located in dorsal–
ventral, animal–vegetal,12 and left–right57 developmental axes of the 8-, and 16-cell 
X. laevis embryo. About 100 molecular features with unique mass-to-charge ratio 
(m/z) and migration time were identified among 3 distinct cell types. A total of 40 
metabolites were identified and combined with chemometric data analysis to 
determine single-cell heterogeneity across the analyzed developmental axes. An in-
depth overview of CE-MS and single-cell metabolomics is presented in Chapter 2.  
1.3 Research significance and motivation 
To study metabolism in individual embryonic cells during early 
embryogenesis, the Nemes Lab uses the South African clawed frog (Xenopus laevis), 
a well-established vertebrate model for molecular, cell and developmental biology 
studies. This animal model offers several advantages, for example: i) embryonic cells 
of the X. laevis are considerably large during early development, which facilitates the 
development and validation of new bioanalytical technologies, ii) tissue fates have 
been carefully mapped for every embryonic cell in the 16-58 and 32-cell59 embryo, 
allowing us to test functional significance of our metabolic data on cell fate 
commitment, and iii) the X. laevis frog offers a reliable year-round supply of embryos 
with rapid external development that agrees with faster experimental protocols.  
Recently, our lab characterized metabolites in whole X. laevis embryonic cells 
using CE-ESI-MS12 and uncovered previously unknown single-cell heterogeneity 
among cells in the early developing embryo (Figure 1.3A). Comparing metabolic 






has a unique metabolic profile. To test functional significance of the measured 
metabolite differences across the dorsal–ventral cell types, our lab conducted a series 
of microinjections containing a mixture of metabolite standards and a fluorescent 
tracer to investigate likely effects on tissue fate. Remarkably, it was found that 
altering the native abundance of metabolites in dorsal and ventral cells influenced 
their tissue fates (Fig. 1.3B). For example, when injecting the animal-dorsal D11 cell 
at the 16-cell embryo with a mixture of metabolites found to be enriched in the 
ventral V11 cell, such as acetylcholine and methionine, it was found that the neural-
tissue fate of the D11 cell at the larval stage (Figure 1.3B, Top panel) was changed to 
an epidermal-tissue fate (Figure 1.3B, Bottom panel). However, the underlying 
molecular mechanisms that link metabolites and their contribution to the phenotypic 
changes in tissue fate observed in the X. laevis embryo remains unknown by us and 
others in the developmental biology community. 
 
 
Figure 1.3 Developmental axes and cell fate lineage of the X. laevis embryo. Key: b–








In this dissertation work, I developed single-cell analytical tools and 
applied them to expand metabolomic analysis in X. laevis during early 
embryonic development. To enable single-cell analysis, a new sampling approach to 
conduct in situ, minimally invasive sampling of the X. laevis embryo was devised.55 
This approach incorporates a fabricated microprobe to aspirate a small volume (~10 
nL) of the cell without damaging or hindering embryonic development, which is 
discussed among recent technological advances in single-cell CE-MS in Chapter 2. 
Next, a custom-built CE-MS platform was adapted to enable dual analysis of cationic 
and anionic metabolites from single cells (Chapter 3). In Chapters 4 and 5, I utilized 
these technologies to study single-cell metabolic heterogeneity in the early X. laevis 
developing embryo. Finally, Chapter 6 reflects on the current state of single-cell 
metabolomics with mass spectrometry, emphasizing existing challenges and 
emerging methodologies that are needed to continue to push the field onwards. 
 
 






Chapter 2: Current state of single-cell metabolomics with 
capillary electrophoresis–mass spectrometry 
 
This chapter includes material adapted with permission from:  
R.M. Onjiko, E.P. Portero, S.A. Moody, and P. Nemes*, In situ microprobe single-
cell capillary electrophoresis mass spectrometry: Metabolic reorganization in single 
differentiating cells in the live vertebrate (Xenopus laevis) embryo, Anal. Chem. 
2017, 89, 13, 7069–7076. https://doi.org/10.1021/acs.analchem.7b00880 
 R.M. Onjiko, E.P. Portero, and P. Nemes*, Single-cell metabolomics with capillary 
electrophoresis- mass spectrometry. Royal Society of Chemistry, 2018, 
https://doi.org/10.1039/9781788012737-00209 
 
2.1 Fundamentals of capillary electrophoresis  
 
 Capillary electrophoresis is a separation method in which a charged analyte 
migrates inside a thin capillary, under the influence of an electric field. Originally, CE 
was primarily used for the analysis of biological macromolecules but over the last 
decades, CE has proven to be useful for the separation of several types of compounds 
(e.g., amino acids, chiral drugs, vitamins, pesticides, dyes, etc.). The mechanism of 
separation in CE relies on the differences in ion velocities (v) under the influence of 
an electric field (E) (see Equation 2.1), and where µ  corresponds to the constant 
electrophoretic mobility of the ion.  






Since the electrophoretic mobility of an ion depends on its charge-to-radius ratio (q/r) 
and the viscosity (η) of the buffer, it can be represented as follows (Equation 2.2):  
µ =                (2.2) 
 
Therefore, µ  depends on the ion’s size and charge, as well as the chemical properties 
of the buffer.60 For instance, Equation 2.2 establishes that small and highly-charged 
species will depict higher mobilities compared to their neutral and less charged 
counterparts.  
 CE separations are also dependent on the electroosmotic flow (EOF). The 
EOF is the bulk flow of liquid within the capillary that originates when ions from the 
solution are present in an applied electric field that encounters a charged solid 
surface. Moreover, since the charge on the capillary wall is highly dependent on pH, 
the extent of the EOF can be adjusted by altering several factors including the coating 
of the capillary wall, ionic strength of the buffer, or pH of the buffer.  
 During CE separation, a narrow-bore fused-silica capillary (inner diameter 
<100 µm) is filled with a background electrolyte buffer (BGE), the sample is 
introduced at the inlet, and the electrical field is applied (Figure 2.1). While small and 
highly-charged ions move faster than larger ions, solutes also move towards the 
electrode of opposite charge (e.g., cations migrate towards the cathode, anions 
towards the anode). However, the ions also move through the capillary in the 
direction determined by the EOF, regardless of charge. For example, ions moving in 
opposite direction of the EOF are still flushed to the detector since the EOF exerts 
more force than their effective electrophoretic mobility. Thus, cations, neutrals, and 






Since the electro-driven force of the EOF is uniformly distributed along the 
capillary wall, the velocity of the separating ions is nearly identical, resulting in a flat 
flow velocity profile.61 The flat flow profile is beneficial because it does not 
contribute to peak broadening as compared to laminar flow velocity profiles (e.g., in 
liquid chromatography). In CE, the separation efficiency is expressed in number of 
theoretical plates (N) (Equation 2.3) where (µ) is the apparent mobility of the ion and 
(D) is the diffusion coefficient of the solute:  
                                                             𝑁 =
µ
                                                         (2.3) 
The theoretical plate numbers in CE are estimated to be ~1 million.62 Consequently, 
the theoretical plate height (H), which is a measure of chromatographic efficiency, 
will result in a small value. For instance, when applying the Van Deemter equation63 
(Equation 2.4) for CE separations, the eddy diffusion (A) and mass-transfer (C) terms 
are eliminated due to the absence of column packing and solute-wall interactions. 
Thus, the plate height depends only on the longitudinal diffusion (B) coefficient in 
CE under ideal conditions. 







Figure 2.1 Capillary electrophoresis separation depends on the electroosmotic flow 
(EOF) and electrophoretic mobility of the ionic species. Cationic species migrate 
from the anode (+) towards the cathode (–) in a fused silica capillary. 
 
2.2 Introduction to single-cell metabolomics with CE-MS 
 
Single-cell analysis promises to be a new frontier in the study of how cells 
of identical genotype execute molecular programs to acquire important functional 
differences.12, 56, 64-66 Molecular analysis with single-cell resolution provides 
biomolecular insights that would otherwise be masked due to signal averaging by 
conventional approaches that pool cells for analysis. Characterization of the single-
cell metabolome comes with analytical challenges. Metabolites have diverse 
physicochemical properties (e.g., pKa and hydrophobicity), are highly dynamic, and 
cover several orders of magnitude in abundance.64 Compounding these challenges, 
single cells vary broadly in size across the phyla and even in the same organisms, 






metabolome requires specialized analytical techniques, particularly those capable of 
low detection limits, high molecular specificity, quantification, and sufficient speed to 
probe metabolic changes with potentially high turn-over rates.  
Single-cell mass spectrometry (MS) is one such technology that enables the 
characterization of metabolites in single cells. Technologies of single-cell MS employ 
diverse experimental conditions to provide small-molecule measurements with 
scalability in molecular coverage, spatial and temporal resolution, and/or operation 
under denaturing or native conditions. An overview of single-cell MS is available in 
references64, 68-73. A subset of single-cell MS technologies employs some form of 
separation to advance the detectable coverage of the single-cell metabolome. Liquid-
phase separation before electrospray ionization (ESI) MS aids molecular detection by 
obtaining compound-dependent information, viz. the time a compound spends in 
separation, and/or by removing interferences during ion generation or spectral 
detection. Additionally, gas-phase separation in an ion mobility analyzer helps reduce 
spectral interferences and quantify collision-cross sections as compound-dependent 
information. This strategy has detected ∼400 ion signals and identified 23 metabolites 
and lipids from single A. thaliana cells.29  
This chapter reviews trace-sensitive CE-MS, which has demonstrated several 
advantages for single-cell metabolomics.70 Perhaps most importantly, CE is 
compatible with the limited sample volumes that are contained by single cells. CE 
also obtains exquisite separation peak capacity to efficiently reduce the complexity of 
metabolite mixtures and help distinguish isobaric compounds prior to detection. The 






(ESI) MS and developed specialized workflows to detect hundreds of metabolite 
features in single cells.  
The general approach of single-cell studies is presented in Figure 2.2. The 
workflow begins with the identification and isolation of cells and is followed by 
sampling of their content before metabolites are extracted. In CE, extracted 
metabolites are separated based on differences in electrophoretic mobility, are ionized 
(usually by ESI), and metabolite ions are detected by MS–MS/MS. With a thoughtful 
experimental design, it is possible to identify metabolite signals and quantitatively 
compare their profiles between cells. By quantifying hundreds of metabolite features, 
CE-ESI-MS has enabled us to distinguished cells and cell types based on metabolic 
composition, including single neurons in the central nervous system of the giant sea 
slug (Aplysia californica)14, 65, 76 and embryonic cells of the 8-,30, 57, 74 16-,12, 55 and 
32-cell55  embryo of the South African clawed frog (Xenopus laevis). Furthermore, 
data from these studies have allowed us to design functional experiments that led to 
the discovery of small molecules capable of altering the normal tissue fate of 
embryonic cells.12 The next sections provide an overview of the major steps of the 







Figure 2.2 Workflow for single-cell metabolomics. Reproduced from ref. 41 with 
permission from The Royal Society of Chemistry. 
 
2.3 Sampling of single cells 
 
The goal of this step is to collect cellular content from individual cells, providing 
the “sample” for further processing prior to CE-MS (Figure 2.2). Depending on the 
purpose of the study, cell sampling may involve an initial step to define cells of a 
particular phenotype before sampling commences. Morphology and established cell 
maps have allowed the distinction of cell types in powerful biological models, such as 
individual neurons in the central nervous system of Aplysia californica,14 crabs,77-78 
and Drosophila melanogaster (fruit fly).79 Likewise, based on cell morphology and 
cell fate maps,58-59, 80 we have identified cells occupying the left–right, dorsal–ventral, 
and animal–vegetal axes of the X. laevis embryo and used single-cell CE-ESI-MS to 
compare their metabolomic composition. These studies revealed that the neural-tissue 
fated D11 cell, the epidermal-fated V11 cell, and the hindgut-fated V21 cell produced 
distinct metabolomes in the 16-cell X. laevis embryo.12 Cell types may also be 






before chemical analysis. For example, metabolites were recently measured in 
excitatory glutamatergic and inhibitory GABAergic neurons in the rat brain by CE-
MS.56 For cell types that express known molecular markers, high-resolution 
fluorescence imaging facilitates cell identification. The success of this approach is 
exemplified by in situ hybridization marking neurons in the A. californica central 
nervous system during development, neurogenesis, and metamorphosis.81 Similarly, 
molecular markers allow fluorescence or magnetic activated cell sorting (FACS or 
MACS, resp.) to separate particular cell types in high-throughput from cell 
suspensions (see reviews in ref.82-88).  In developing biological systems, optical 
imaging may be necessary to identify cells in precursor–progenitor relationships. For 
example, we have used morphology (e.g., pigmentation and size) and fluorescent 
dyes to track cell clones in the 8-, 16-, 32-, 64-, and 128-cell X. laevis embryo before 
characterizing their small molecules12, 55, 57, 89 and proteins9, 19, 90 by CE-ESI-MS. 
Alternatively, high-throughput imaging by single-cell MALDI MS enables the 
recognition of cell types based on chemical composition without information of 
phenotype, morphology, or location, as recently demonstrated for cells in rat 
pancreatic islets.31  
To collect a portion of whole cells, different technologies have been developed 
with scalability in size and collection speed (Figure 2.3). Manual dissection31, 91 is 
readily amenable to larger cells. As shown in Figure 2.3A, sharp tungsten needles, 
fine forceps, or finer tools have been used to isolate 50–500 μm cells from A. 
californica,14 a mouse ganglion,56 or X. laevis embryos.12, 57, 92 With a modest 






origin of isolated cells, which can add important information to address biological 
questions, such as signaling molecules expressed in neuronal circuits14, 56, 76 or 
metabolites implicated in cell-fate decisions.12 For smaller cells, which challenge 
dissection accuracy, approaches capable of finer resolution were introduced. 
Sharpened or pulled capillaries were found to be able to reproducibly target and 
aspirate picoliter-to-nanoliter volumes from rat thalamic neurons,56 tomato trichome 
cells,93 and frog embryonic cells,55 as shown in Figure 2.3A. Capillaries containing 
dual barrels helped enhance the throughput of these measurements. Figure 2.3B 
exemplifies how this strategy was able to collect metabolites from multiple Allium 
cepa cells.94 Fluid force microscopy takes an alternative approach, in which a 
cantilever is driven by an atomic force microscope to probe subpicoliter volumes 
from human cervical cancer (HeLa) cells (Figure 2.3C).95 
Capillary sampling has also been coupled to CE-MS. Representative examples 
include the metabolic study of single neurons in the rat thalamus56 and single X. 
laevis cells.12, 55 In both cases, microsampling allowed the same cell to be sampled 
multiple times. Surprisingly, in situ microsampled cells were found to continue cell 
division as the embryo developed to the next stage.55 Alternatively, fluid force 
microscopy95 or laser capture microdissection96 may be used to sample cells. 
Recently, a combination of MALDI-MS and CE-ESI-MS was used to differentiate 








Figure 2.3 Examples of approaches enabling single-cell sampling. (A) Fine-pulled 
capillaries were used to withdraw the cytoplasm of a single thalamic neuron in the rat 
brain, a single type VI stalk cell from intact tomato trichomes, and the right ventral-
animal (V1) cell in the 8-cell Xenopus laevis embryo. (B) A dual-barrel pipette for 
sampling individual A. cepa cells. (C) Fluid force microscopy probe was used to 
aspirate the cytoplasm from HeLa cells. (D) Using a liquid junction interface, 
metabolites were extracted from identified cells in a rat pancreatic islet for MALDI. 
Reproduced from ref. 41 with permission from The Royal Society of Chemistry. 
  
High-fidelity sampling is essential since it can greatly aid with result 
interpretation in single-cell studies. With sufficiently fine spatial resolution, cross-
contamination can be eliminated or, at least, assigned to neighboring cells. Fast 
sampling can minimize metabolic changes arising from endogenous metabolism, 
transitions in cell cycle, or metabolic degradation, thus providing a credible snapshot 
of the cell's metabolic activity state. Using capillary microsampling, we recently 
aspirated a portion of identified embryonic cells with a 5 s/cell throughput (Figure 
2.4A), compared to 5 min/cell by manual dissection. With minimal damage to the 
cell, capillary microsampling CE-MS significantly lowered oxidative stress during 
sampling (Figure 2.4B), thus yielding metabolomic data that more closely represent 







Figure 2.4 Microprobe sampling and metabolite detection by CE-MS. (A) 
Microprobe CE-MS workflow enables in situ metabolic characterization of live X. 
laevis embryos. (B) Representative electropherograms show a decrease in oxidative 
stress (GSSG/GSH) by microprobe sampling. Adapted with permission from ref. 55. 
Copyright 2017 American Chemical Society.  
 
2.4 Metabolite extraction 
Immediately after sampling, the whole cell or a collected portion of its content 
is processed to preserve and extract endogenous metabolites. Enzymes may be 
deactivated/denatured by inhibitors, chemicals, or temperature-shock.97-98 We and 
others have found the combined use of volatile organic acids (e.g., formic/acetic 
acid), volatile organic solvents (e.g., methanol/acetonitrile mixtures with water), and 
low temperatures (4 °C) during sample processing to be sufficient to stabilize the 
extracted metabolites for up to 1 month when the extracts are stored frozen at −80 
°C.12, 55, 57, 99 The chemical stability of the extract may be improved by addition of 






reproducibility of metabolite quantification by 4-fold in single A. californica 
neurons.76  
Next, metabolites are extracted from the collected specimen using solvents. 
To broaden detection coverage, extraction typically exploits a combination of 
solvents that are tailored to the physicochemical properties of the compound classes 
of interest (e.g., amino acids, lipids, or sugars). In addition, the pH of the solvent is 
adjusted to facilitate ionization. The extraction solution may consist of miscible or 
immiscible solvents with the latter allowing for subsequent fractionation. Because 
cells can exhibit varying physical properties and chemical compositions, even in the 
same tissue or organisms, we recommend optimizing and validating the method of 
extraction using the cells of interest. We found modeling the physicochemical 
properties to be helpful in guiding the initial design of single-cell experiments. Figure 
2.5A shows an example in which the octanol/water distribution coefficients (D) were 
calculated at different pHs, which helped select a series of polar–apolar solvent 
mixtures to enhance the extraction of select metabolite classes from single X. laevis 
cells (Figure 2.5B).57 In addition, we also found the use of chemical standards to be 
ideal to establish the optimal pH and solvent composition for enhanced quantitative 
recovery and ionization efficiency, as well as to tune the ESI mass spectrometer for 
sensitivity. 
To enhance the analytical performance of single-cell CE-ESI-MS, extraction 
may be supplemented with additional steps. Internal standards added to the extraction 
solvent system or the resulting extract can help with qualitative and quantitative 






CE separation, as well as correcting for fluctuations in ESI-MS performance (e.g., by 
normalization). An isotopologue of the analyte serves as the internal standard of 
choice because it has similar physicochemical properties to the metabolite of interest 
without interference in detection. Depending on endogenous concentration and 
detection sensitivity, pre-concentration steps (e.g., off-column or on-column) may be 
necessary to enrich metabolites with low abundances. Desalting or fractionation steps 
may be performed to reduce sample complexity and matrix interferences, albeit at the 
risk of analyte losses and/or modifications to the metabolome. We have found 
simplicity and speed to be efficient guides during the design of our single-cell 
metabolomic workflows.12, 57 
Another purpose of extraction is to improve separation by CE and detection 
by ESI-MS. Extraction has the benefit of simplifying the molecular complexity of the 
extract, thus removing potential interferences during ion generation by ESI and mass 
analysis (spectral) by MS. Microprobe CE-ESI-MS, which aspirates small amounts of 
cellular content (∼10 nL), was found to improve the separation and yield a 
comparable signal-to-noise ratio to whole-cell (∼90 nL) dissected samples (Figure 
2.4B). The improvement was attributed to the ability of capillary microsampling to 
collect substantially smaller amounts of salts, buffers, and other additives from the 








Figure 2.5 Sample processing strategies for improved detection sensitivity in single-
cell CE-MS. (A) Modeling of physicochemical properties, such as the distribution 
coefficient (D), helps guide the selection of extraction solvents. (B) Extraction using 
solvents with different pH and polarity enhanced metabolic coverage in single X. 
laevis cells. PolarpH4, 50% methanol with 0.5% acetic acid; ApolarpH4, 40% 
acetonitrile with 40% methanol; ApolarpH8, 40% acetonitrile with 40% methanol at 
pH 8. Reproduced from ref. 41 with permission from The Royal Society of 
Chemistry. 
2.5 Detection by capillary electrophoresis–mass spectrometry 
Next, the cellular aspirate is analyzed by CE-ESI-MS, which entails a subset 
of tasks: the sample is injected into a separation capillary, metabolites are separated 
based on differences in their electrophoretic mobility, ionized by ESI, and the 
generated metabolite ions are mass-analyzed using a mass spectrometer (Figure 2.2). 
With nano-liters of sample consumption, CE is ideally suited to analyze metabolites 
in volume limited extracts from single cells. The Sweedler65, 100 and Nemes9, 12 
laboratories have custom-built single-cell CE-ESI platforms for MS. Construction and 
operation of these CE ESI-MS platforms follows a prototype published in ref.100-101 






confined within an electrically insulated enclosure equipped with a safety interlock. 
To load ∼10 nL of sample into the separation capillary, a <1 μL portion of the cell 
extract is deposited into a sample vial where the CE capillary is positioned and then 
the injection platform is elevated to enable hydrodynamic injections of the sample. 
CE separation is performed by translating the capillary inlet end into the background 
electrolyte (BGE) and applying ∼20 kV across the ∼1 m long capillary. 
 
 
Figure 2.6 A custom-built CE-ESI-MS platform for characterizing metabolites in 
single-cells. (a) Major components include: (1) a safety-interlock-enabled enclosure, 
(2) a sample loading platform, (3) a holder for (4) a fused silica separation capillary, 
(5) a resistor, (6) and a digital multimeter. (b) A close-up view of the sample-loading 
platform: (7) a sampling vial and (8) background electrolyte vial. (c) The CE-ESI-MS 
ionization source: (9) the CE-ESI interface on a (10) three-axis translation stage, (11) 
a camera to monitor the ESI interface, and (12) a mass spectrometer. (d, e) A 
magnified view of the T-union that connects the (4) separation capillary, (13) 
secondary capillary supplying sheath solvent, and the (14) metal-emitter for 
generating the electrospray in the (15,16) cone-jet regime. Reproduced from ref. 41 






ESI is the most commonly used technology to ionize CE-separated 
metabolites for MS detection. CE-ESI interfaces vary greatly in design and 
performance (see reviews in ref.102-104). We apply a modified form of the original co-
axial sheath-flow design,105 which has been found to provide robust operation since 
inception. In our design, the nebulizer gas is removed to help direct the electrospray 
plume to the mass spectrometer, the dimensions of the emitter are scaled to the 
separation capillary to minimize sample dilution in the ion source, and the geometry 
of the electrospray emitter and the operation parameters are carefully chosen to 
maintain the electrospray in the stable cone-jet regime, which provides the most 
efficient ionization.106 This CE-ESI interface provides a 60 amol lower limit of 
detection and 4–5 log-order dynamic range for quantification.12 Furthermore, we have 
most recently developed a second-generation version of this interface, which uses a 
tapered-tip emitter to achieve 260 zmol (156 000 copies) sensitivity for peptide 
standards.107 These CE-ESI-MS platforms have allowed the detection of hundreds of 
metabolite signals from single cells that were isolated from A. californica neurons100 
and X. laevis embryonic cells,12, 55, 57 including the identification of ∼100 metabolites 
with significant metabolic differences between cell types. Development and recent 
commercialization of alternative designs, such as low-flow sheath108 and sheathless109 
interfaces, raise opportunities to further the sensitivity of CE-ESI for single-cell 
metabolomics. 
Various strategies can be applied to enhance the throughput of single-cell 
measurements using CE-ESI-MS. For example, capillary batch injection enables 






sensitivity for low abundance metabolites, online preconcentration methods, such as 
sample stacking,111 can be incorporated into the workflow. Figure 2.7A shows large-
volume sample stacking allowing nucleotides to be detected from a 60 μm A. 
californica neuron.112  For higher throughput, multi-segmented injection offers 
significant benefits. Figure 2.7B presents one such example, in which human plasma 
extracts were measured 10-times faster, with ∼3 min per sample throughput without 




Figure 2.7 Recent advances to enhance CE-MS measurement throughput and 
sensitivity. (A) Large-volume sample stacking improved detection sensitivity. (B) 
Multi-segmented injection enhanced throughput to 3 min/sample. (C) CE with 
desorption electrospray ionization (DESI) minimized ion suppression effects due to 
salts and detergents. (D) Optically guided MALDI-CE-MS screened large numbers of 
cells based on peptide and metabolite composition. Reproduced from ref. 41 with 







Other ionization sources provide complementary benefits to single-cell CE-
MS. Figure 2.7C shows the hyphenation of CE to desorption electrospray ionization 
(DESI): the separated compounds are dried onto a rotating teflon disk, whence they 
are desorbed and ionized by focused charged droplets with improved tolerance for 
salts and detergents.114 Figure 2.7D presents another setup in which MALDI was off-
line coupled to CE-MS to profile cells in rat pancreatic islets.31 After α- and β-cell 
types were distinguished based on their peptide content,72, 115 the dried samples were 
microextracted for metabolic analysis by CE-ESI-MS. To broaden the coverage of the 
metabolome, both negative112 and positive ionization modes may be used and/or 
multiple analytical platforms combined. 
2.6 Data processing 
The last step of the workflow is aimed at identifying and/or quantifying 
metabolite signals between single cells (Figure 2.2). CE-ESI-MS studies utilize 
multiple dimensions of information to this end, including accurate m/z, migration 
time, fragmentation, and peak intensity/area. Representative separations are 
demonstrated for select metabolite signals in Figure 2.8A. Comparison of these 
orthogonal pieces of information makes confident identification possible for any 
metabolite that can be obtained as a chemical standard or for which tandem MS 
information is available in a tandem MS database, such as mzCloud and Metlin.116 
For example, Figure 2.8A shows a signal at m/z 175.1188 in the D11 cell from the 16-
cell X. laevis embryo with identification as arginine based on accurate m/z and MS–






provide a proxy for relative quantification, and with the use of external concentration 
calibration, for absolute quantification. Figure 2.8B exemplifies the quantification of 
serine in the R15 and left pleural 1 (LPl1) cell of A. californica via concentration 
calibration.12, 14, 100 Quantification provides a powerful tool for targeted or discovery 
characterization of cells or cell types, particularly when combined with statistical or 
multivariate tools, such as hierarchical cluster analysis (HCA), partial least squares 
discriminant analysis (PLS-DA ), or principal component analysis (PCA). For 
example, Figure 2.8C shows HCA of metabolites with significant enrichment 
differences between three cell types in the same 16-cell embryo of X. laevis. These 
data analysis tools are available in many publicly available software packages, 
including XCMS,117 MetAlign,118 MSFind, MS-DIAL,119 MetaboAnalyst,120 







Figure 2.8 Identification and quantification of small molecules in single cells. (A) 
Electropherogram showing select identified small molecules measured from an 
individual cell derived from a 16-cell Xenopus laevis embryo. Representative 
identification of a metabolite signal as arginine in a X. laevis cell (B) Quantification 
of serine in different R15 and LPl1 neurons of A. californica. (C) Hierarchical cluster 
analysis differentiating the D11, V11, and V21 cells in 16-cell Xenopus laevis 
embryos and volcano plot shows significant metabolite differences between the cells. 










CE and MS combine excellent analytical figures of merit for single-cell 
metabolomics. CE is compatible with the limited amounts of material that are 
contained in cells and has exquisite separation resolution to address complex 
metabolite extracts. Various on-column pre-concentration techniques by CE enhance 
detection to trace-level sensitivity (e.g., ∼60 amol or 10 nM by FACS), allowing one 
to measure metabolites over broad dynamic concentration ranges exhibited in 
biological systems. MS detection complements CE with high molecular specificity, 
label-free operation, and capability for quantification of broad types of metabolites in 
cells. Data resulting from single-cell CE-MS has shed new light on small-molecule 
differences between cells in various tissues and model organisms, ranging from 
metabolites in early stages of developing vertebrate embryos12 to signaling molecules 
in the nervous system.123  
Continuing technological advances promise exciting opportunities to advance 
our understanding of cell biology.53 Sampling approaches with faster operation and 
scalability in space and time allow a larger number of cells to be probed, thus 
enhancing statistical power to uncover differences between cells and to characterize 
cells at the whole population level. These developments in fast sampling can be 
supported by analyses capable of higher throughput, including sample processing on 
microfluidic devices,124 separation by microchip electrophoresis,125 and ionization by 
MALDI31, 70 or ESI12, 65, 100 mass spectrometers. To analyze the large amounts of 
complex data from these studies, software tools capable of statistical and multivariate 






level signals that are expected from single-cell studies. Parallel advances in the steps 
of the single-cell CE-MS workflow can help extend this powerful bioanalytical 
technology to systems biology studies on cells and limited cell populations, 







Chapter 3: Enabling dual cationic–anionic profiling of 
metabolites in a single cell of the Xenopus laevis embryo by 
CE-ESI-MS  
 
This chapter has been published as a peer reviewed journal article. Reproduced from: 
E.P. Portero and P. Nemes*, Dual cationic–anionic profiling of metabolites in a single 
identified cell in a live Xenopus laevis embryo by microprobe CE-ESI-MS, Analyst, 
2019, 144, 892–900. https://doi.org/10.1039/C8AN01999A with permission from The 
Royal Society of Chemistry. 
 
In situ microprobe sampling and CE-ESI-MS enabled the characterization of 
cationic metabolites in single cells in complex tissues and organisms.55  However, for 
a deeper coverage of the metabolome and metabolic networks, analytical approaches 
are needed that provide complementary detection for anionic metabolites, ideally 
using the same instrumentation. This chapter describes the development of a CE-ESI-
MS approach that enables sequential cationic and anionic (dual) analysis of 
metabolites in the same identified cell in a live vertebrate embryo. A calibrated 
volume was microaspirated from the animal-ventral cell in a live 8-cell embryo of 
Xenopus laevis, and cationic and anionic metabolites were one-pot microextracted 
from the aspirate, followed by CE-ESI-MS analysis of the same extract. A laboratory-
built CE-ESI interface was reconfigured to enable dual cationic–anionic analysis with 
∼5–10 nM (50–100 amol) lower limit of detection and a capability for quantification. 
To provide robust separation and efficient ion generation, the CE-ESI interface was 






optimized for the cone-jet spraying regime in both the positive and negative ion 
mode. A total of ∼250 cationic and ∼200 anionic molecular features were detected 
from the cell between m/z 50–550, including 60 and 24 identified metabolites, 
respectively. With only 11 metabolites identified mutually, the duplexed approach 
yielded complementary information on metabolites produced in the cell, which in turn 
deepened network coverage for several metabolic pathways. With scalability to 
smaller cells and adaptability to other types of tissues and organisms, dual cationic–
anionic detection with in situ microprobe CE-ESI-MS opens a door to better 
understand cell metabolism. 
3.1 Introduction 
 
Single-cell mass spectrometry (MS) provides a molecular snapshot to 
investigate the phenotypical and physiological state of a cell;64 the technology is 
qualitative, capable of label-free detection, and can be made quantitative. As a 
downstream product of transcription and translation, the metabolome, comprising of 
all metabolites produced by a cell, responds dynamically and rapidly to intrinsic and 
extrinsic events to the cell. Therefore, the single-cell metabolome raises a new 
frontier in the study of molecular events underlying cell differentiation and the 
establishment of cell-to-cell differences (cell heterogeneity) during normal and 
impaired development. 
 Detection of the single-cell metabolome presents grand analytical challenges 
for MS since the metabolome encompasses vast molecular complexity and spans a 






dimensions as cells develop and different physical and temporal positions that they 
assume in tissues and developing organism. For example, blastomeres become 
progressively smaller and undergo long-range movements during morphogenesis in 
vertebrate embryos.126 To better understand cell metabolism, specialized approaches 
are required that integrate spatially and temporally scalable sample collection, 
particularly in complex tissues and organisms, with trace-sensitive MS for broad 
types of metabolites. 
 Recent developments in CE-MS technology raise a potential toward anionic 
metabolomics in single cells (see reviews in ref.127-130). Low limits of detections 
(∼10–200 nM) and high measurement reproducibility were accomplished for anions 
from metabolite standards and extracts of tissues and biological fluids using CE-MS 
interfaces that employ sheathflow,112, 131 low-flow electrokinetically-pumped,26, 132 
and sheathless75 interface designs. Nucleotides were most recently profiled in single 
neurons from Aplysia californica using a coaxial sheath-flow CE-ESI interface.112 In 
principle, the combination of cationic and anionic analysis holds the potential to 
deepen metabolic coverage in single cells. However, individual cells contain 
prohibitively limited amounts of materials for independent sample processing that is 
typical for cationic and anionic analysis. Additionally, complex CE-ESI interface 
designs and the use of different CE capillaries for cationic and anionic measurements 
(e.g., chemically derivatized capillaries) lower analytical throughput, hindering the 
analysis of multiple single cells to facilitate results interpretation. 
 Described here is a simplified methodology that enables the dual analysis of 






microsampling to collect cell material from identified single cells in live X. laevis 
embryos, which was followed by a one-pot micro extraction of anionic and cationic 
metabolites from the collected material. A custom-built sheath-flow CE-ESI interface 
was supplemented with a nitrogen gas filled environmental chamber to minimize 
electrical discharges at the electrospray emitter to ensure stable and efficient ion 
generation for detection. Cationic and anionic analysis using the same bare fused 
silica capillary with different background electrolytes provided complementary 
metabolite identifications, yielding a deeper coverage of metabolic networks than was 
feasible using each approach in isolation using single-cell CE-ESI-MS. 
3.2 Experimental 
3.2.1 Chemicals 
 LC-MS grade solvents and chemicals including formic acid, ammonium 
bicarbonate, methanol, acetonitrile, isopropanol, and water were purchased from 
Fisher Scientific (Fair Lawn, NJ), unless otherwise noted. Trizma hydrochloride and 
trizma base were obtained from Sigma Aldrich (Saint Louis, MO). Cysteine was from 
MP Biomedicals (Solon, OH). 
3.2.2 Solutions 
 Steinberg’s solution (100% v/v) and cysteine solution (2% v/v) were prepared 
following standard protocols.126 The “metabolite extraction solvent” consisted of 40% 
(v/v) methanol and 40% (v/v) acetonitrile in water (pH 4.7). For cationic analysis, the 






the electrospray sheath solution was 50% (v/v) methanol in water containing 0.1% 
(v/v) formic acid. For anionic analysis, the BGE was 20 mM ammonium bicarbonate 
(pH 8.2), and the electrospray sheath solution was 0.2 mM ammonium bicarbonate in 
50% (v/v) isopropanol. 
3.2.3 Animal care and embryo collection  
 All protocols regarding the humane care and handling of animals were 
approved by the University of Maryland Institutional Animal Care and Use 
Committee (IACUC no. R-DEC-17-57). Male and female adult Xenopus laevis frogs 
were purchased from Nasco (Fort Atkinson, WI) and maintained in a breeding 
colony. Embryos were obtained via gonadotropin-induced natural mating following 
established protocols.126 The jelly coating of freshly laid embryos was removed as 
described elsewhere.133 Dejellied embryos were transferred to a Petri dish containing 
100% Steinberg’s solution (SS). Two-cell stage embryos showing stereotypical 
pigmentation patterns134 across the dorsal-ventral and left-right axis were cultured in 
100% SS to the 8-cell stage for this study. 
3.2.4 Single-cell sampling and metabolite extraction 
 The left animal-ventral (V1) cell was identified in 8-cell embryos in reference 
to established cell-fate maps.135 An ∼10 nL aliquot of cellular content was aspirated 
from the cell using microcapillary sampling following our recent protocols.55, 101 To 
extract small polar metabolites from the aspirate, the sample was expelled into 4 μL 
of metabolite extraction solution at ∼4 °C and vortex-mixed for ∼1 min at room 






Metabolite extracts were stored together with the cell debris at −80 °C until CE-ESI-
MS analysis. 
3.2.5 Single-cell CE-ESI-MS 
  Single-cell metabolite extracts were measured using a laboratory-built 
microanalytical CE-ESI system coupled to a quadrupole time-of-flight mass 
spectrometer (Impact HD, Bruker Daltonics, Billerica, MA), following our 
established protocols.12, 55, 101 In this study, CE separation was performed in a 1-meter 
long bare fused silica capillary with 40/105 μm inner/outer diameter (Polymicro 
Technologies, Phoenix, AZ) with the outlet end grounded using a custom-built 
coaxial sheath-flow CE-ESI interface.100 Cationic analysis implemented the following 
parameters: CE separation at +20–22 kV (applied to capillary inlet) in 1% formic acid 
(yielding ∼7.5–8 μA CE current); CE-ESI interface operated in the cone-jet regime 
(0.1% formic acid in 50% methanol supplied at 1 μL min−1 as sheath flow) at −1700 
V spray potential applied to mass spectrometer front plate; CE-ESI environmental 
chamber, no nitrogen supplied (ambient air as bath gas). Anionic analysis was 
performed using the following settings: CE separation at +17–19 kV (applied to 
capillary inlet) in 20 mM ammonium bicarbonate (yielding 4.9–5.6 μA CE current); 
CE-ESI interface operated in the cone-jet electrospray regime (0.2 mM ammonium 
bicarbonate in 50% isopropanol supplied at 0.6 μL min−1 as sheath) at +2100 V spray 
potential applied to the mass spectrometer front plate; CE-ESI environmental 
chamber, nitrogen supplied at 0.6 L min−1. In both cationic and anionic 






measurements using a mass spectrometer and by direct optical inspection of the 
electrified liquid meniscus using a stereomicroscope (40× magnification, Simul-Focal 
Stereomicroscope, United Scope, Irvine, CA). Identification of the electrospray 
regimes was performed as detailed elsewhere.106 
 Ions generated by CE-ESI were detected using a quadrupole time-of-flight 
mass spectrometer (Impact HD, Bruker). Experimental settings were the following: 
MS survey scan rate, 2 Hz; mass range (MS1 and MS2), m/z 50–550; collision-induced 
dissociation, 18–20 eV in nitrogen collision gas; dry gas, nitrogen at 2 L min−1 at 100 
°C for positive and 150 °C for negative ionization mode. The mass spectrometer was 
externally mass-calibrated to <5 ppm accuracy by analyzing 150 mM sodium formate 
using CE-ESI in the positive ion mode and directly infusing 10 mM sodium formate 
(in 0.2 mM ammonium bicarbonate prepared with 50% v/v isopropanol) through the 
CE-ESI interface in the negative ion mode. 
3.2.6 Data analysis 
Raw MS-MS/MS data were processed using a custom-written script in 
Compass DataAnalysis version 4.3 (Bruker Daltonics) as described elsewhere.12 
Briefly, each file was externally calibrated to <1 ppm accuracy (enhanced quadratic 
calibration mode) for sodium formate cluster ions that were formed in the ion source 
as salts separated from the samples, molecular features were semi-manually surveyed 
between m/z 50–550 with 5 mDa increments, and the resulting accurate m/z and 
migration time information were recorded for each detected molecular feature. 






using Compass 4.3 (Bruker Daltonics). Metabolic pathway analysis was performed in 
MetaboAnalyst 4.0120 using the Kyoto Encyclopedia of Genes and Genome (KEGG) 
metabolomic knowledgebase (http://www.genome.jp/kegg) with the following 
settings: Pathway library, Danio rerio (zebrafish); pathway analysis algorithms, 
overrepresentation analysis by hypergeometric test and pathway topology analysis by 
relative betweenness centrality. 
3.2.7 Study design 
To account for biological variability, a total of N = 4 different V1 cells were 
analyzed in this study, each from a different embryo from a different clutch over a 
three-month period. For each cell, dual cationic–anionic analysis was performed in 
technical duplicate–triplicate. 
3.2.8 Safety considerations 
Standard safety procedures were followed when handling chemicals and 
biological samples. Capillary micropipettes and electrospray emitters, which pose a 
potential puncture hazard, were handled with gloves and safety goggles. To prevent 
against electrical shock hazard posed by high voltage, all electrically connective parts 
of the CE-ESI setup were earth-grounded and isolated in an enclosure equipped with 






3.3 Results and discussion 
3.3.1 Technology development  
The goal of this study was to enhance the characterization of small polar 
metabolites in single cells, specifically in identified blastomeres directly in live 
embryos. We adapted in situ sampling by a microprobe to a microanalytical 
CE-ESI-MS platform to enable the metabolic analysis of single cells in X. laevis 
embryos.55, 101 This approach allowed the detection of ∼80 identified small polar 
metabolites and revealed quantitative metabolic changes as single cells divide to form 
cell clones in the 8–32-cell embryo.55 However, microprobe CE-ESI-MS was 
restricted to cationic analysis due to frequent electrical breakdowns that destabilized 
the electrospray in the negative ion mode (ESI−). Theoretically, the standard 
metabolomics approach to perform independent analysis of cations and anions can 
deepen the detectable portion of the single-cell metabolome. However, two-step 
metabolite extraction is challenging or incompatible for single cells due to (i) the 
limited amounts of material that are available from a single cell and (ii) cell 
heterogeneity hindering the use of multiple cells, even from the same cell type, for 
sample processing. 
 Here, we addressed this technical limitation by enabling dual cationic–anionic 
characterization of the same single identified cell in live embryos using CE-ESI-MS. 
Our strategy (Fig. 3.1) extended microprobe single-cell sampling55, 101 with 
essentially a one-pot microextraction of cationic and anionic metabolites and also 







Figure 3.1 Microprobe CE-ESI-MS strategy to measure cationic and anionic 
metabolites from the same identified cell in a live X. laevis embryo. Scale bars = 250 
µm. Reproduced from ref. 30 with permission from The Royal Society of Chemistry. 
 
For technology development and validation, the left-ventral (V1) cell was 
used in 8-cell X. laevis embryos (see Fig. 3.1, left panel), which is considerably large 
(∼500 μm in diameter, or ∼180 nL in volume) to facilitate microprobe sampling and 
is readily identifiable based on pigmentation, location, and in reference to established 
cell-fate maps.58, 133-135 An ∼10 nL volume of the identified cell, corresponding to 
∼5% of the total cell volume, was withdrawn using a microfabricated capillary 
mounted to a three-axis translation stage following our recent protocol.55, 101 The 
aspirate was ejected into 4 μL of 40% aqueous acetonitrile containing 40% methanol, 
which efficiently extracts small polar metabolites with different physicochemical 
properties, including acidity and polarity.57 The resulting extract, containing cationic 
and anionic metabolites, thus raised a possibility for enhanced single-cell 






 Anionic analysis required extension of cationic CE-ESI-MS to separation and 
detection of negatively charged metabolites. As an alternative to electron-scavenging 
reagents136-140 or intricate CE-ESI interface designs,26, 75, 112 we opted to refine our 
laboratory-built CE-ESI platform to stabilize electrospray operation in the negative 
ion mode. The setup, shown in Fig. 3.2A, builds on a coaxial sheath-flow interface 
that we12, 55, 74 and others14, 56, 65, 100, 141 extensively used for cationic analysis 
and recently nucleotide detection.112 To minimize/eliminate electrical discharges 
upon negative ion-mode ESI, we enclosed the CE-ESI emitter tip in a lab-fabricated 
environmental chamber that was (optionally) purged with dry nitrogen gas at a 
controllable rate and incident flow angle with respect to the electrospray emitter (see 
“N2 bath gas”). The chamber was directly mounted on the atmospheric pressure 
interface of the mass spectrometer and featured a hole to allow fine-positioning of the 
CE-ESI emitter tip in the chamber in front of the orifice of the mass spectrometer 
inlet. Bidirectional illumination and a long-working distance stereomicroscope were 








Figure 3.2 CE-ESI-MS for cationic and anionic analysis. (A) The CE-ESI-MS 
interface with major components labeled. Microscopy comparison of stable Taylor-
cone in ESI+ (top panel) and nonaxial (rim) emission (middle panel) and electrical 
discharge (spark) in ESI- without nitrogen bath gas. Scale bar = 250 µm (B) Total ion 
chromatograms revealing stable operation during cationic separation with +ESI. 
Astable ESI– with anionic separation was stabilized upon enclosing the electrospray 
emitter in a nitrogen-filled environmental chamber. Spray stability is quantified as % 
relative standard deviation (RSD). Representative mass spectra of a V1 cell extract 
revealing simplified chemical background during ESI–. Pyr, pyridoxal. Reproduced 
from ref. 30 with permission from The Royal Society of Chemistry. 
 
 
 The stability of the CE-ESI-MS system was evaluated. The electro-
hydrodynamic behavior of the liquid meniscus was monitored at the tip of the CE-ESI 






followed using the mass spectrometer. The operational modality of the electrospray 
was identified according to established nomenclature (reviewed in ref.106, 142) as 
follows (see examples in Fig. 3.2, right panel): a stable Taylor-cone with axial spray 
emission marked the cone-jet regime; a pulsating liquid meniscus with axial spray 
emission indicated the burst, astable, or pulsing regimes; non-axial spray emission 
was categorized as “rim emission” in this study. Agreeing with earlier studies (see 
ref.100), the CE-ESI interface yielded stable operation in the cone-jet regime under 
cationic experimental conditions (see Experimental) in air (no nitrogen bath gas 
used). Purging of the environmental chamber with a nitrogen bath gas (ambient 
temperature) at 0.4–1.0 L min−1 maintained stable operation with a variation of ∼6% 
relative standard deviation (RSD) in total ion current (see Fig. 3.2, top panel). 
Therefore, the CE-ESI setup equipped with the environmental chamber still 
maintained robust performance for cationic analysis in this study.  
 The modified CE-ESI setup was tuned for robust anionic analysis. 
Electrospray polarity switching from cationic measurement conditions destabilized 
spray generation (data not shown), which worsened upon replacing the BGE 
with 20 mM bicarbonate, which was previously used for nucleotide analysis.112 
Encouraged by this study, we replaced the electrospray sheath solution with 200 μM 
ammonium bicarbonate in 20%, 50%, and 70% isopropanol to test electrospray 
stability in the negative ion mode. Although the temporal stability of ion generation 
improved using a 50% isopropanol solution (Fig. 3.2, middle panel), a ∼39% RSD in 
the total ion chromatogram (TIC) in our hand revealed still pronounced fluctuation 






transitions between the pulsating (data not shown), rim (see Fig. 3.2 right panel, 
middle inset), and cone-jet electrospray regimes with occasional electrical sparks 
between the emitter tip and the MS orifice plate (see Fig. 3.2 right panel, bottom 
inset). These instabilities in electrostatic spraying and consequent ion generation 
ceased upon continuous purging of the environmental chamber with a steady-stream 
of nitrogen gas. After optimizing the nitrogen gas flow rate at 0.6 L min−1 and 
incidence perpendicularly to the electrospray emitter (see Fig. 3.2), the TIC stability 
was improved to only ∼3% RSD variation. 
 The cationic and anionic separations provided complementary analytical 
performance for detection. For several metabolite standards (e.g., creatine, lysine), 
quantification was tested to be linear between ∼100 nM and ∼1 μM (regression 
coefficient, R2 > 0.99) in both modalities, which the digitizer of the mass 
spectrometer is expected to extend to an ∼4-log-order dynamic range following our 
recent study.12 Based on the analysis of a 100 nM creatine standard, the lower limit of 
detection was extrapolated to 7.5 nM (75 amol) during cationic and 5.5 nM (55 amol) 
during anionic analysis. Furthermore, mass spectra resulting from anionic 
measurements contained substantially fewer background ions, which also had lower 
ion intensities, suggesting minimized spectral interferences compared to cationic 
analysis. Fig. 3.2 exemplifies detection of the pyridoxal anion from a V1 cell extract 
at a ∼3 : 1 analyte : background signal ratio (average ESI−) in a sparsely populated 
spectrum, whereas the cation of this metabolite yielded a ∼1 : 3 ratio in a complex 
mass spectrum from the same cell extract. These analytical figures of merit suggested 






using the same CE-ESI-MS instrument, which we refer to as “dual cationic–anionic” 
measurement in this report. 
3.3.2 Dual cationic-anionic metabolomics of single cells 
We applied these methodologies to characterize small metabolites in N = 4 
single V1 cells (recall Fig. 1). As described earlier, an ∼10 nL portion of the cell was 
aspirated in situ from a live 8-cell X. laevis embryo using a pulled microcapillary. 
Small metabolites were extracted from the aspirate in 4 μL of 40% acetonitrile 
containing 40% methanol. An ∼10 nL portion of the resulting extract was analyzed 
under cationic and then anionic conditions using the same CE-ESI-MS setup and 
different BGEs. Data-dependent tandem MS was performed to facilitate metabolite 
identifications. These measurements, thus, consumed a total of ∼20 nL, viz. ∼0.5% 
of metabolites that were extracted from the V1 cell. Our recent findings using 
microsampling55 suggests that microprobe CE-ESI-MS with dual cationic–anionic 
analysis is scalable to smaller cells and later stages of the developing embryo as well 
as other tissues and organisms. 
 These data provide rich metabolic information on the cell. After deisotoping 
and manual annotation of the MS data, we found ∼250 cationic and ∼200 anionic 
nonredundant molecular features between m/z 50–550. These numbers excluded non-
covalent clusters as well as signals that originated from the extraction solvents or the 
culturing media (e.g., polymers from vials and salt peaks). Metabolite identifications 
were made for 60 cationic and 24 anionic molecular features (Table 3.1) based on 






MS-MS/MS data recorded on chemical standards, in our previous studies,12, 55, 57, 74 or 
published in Metlin43 and MzCloud (http://www.mzcloud.org).  
Table 3.1 Metabolites identified by cationic–anionic microprobe CE-ESI-MS.  
Positive ion mode 











1 Spermidine (SPM)** C7H19N3 15.5 146.1663 146.1652 –1.1 –7.5 
2 Thiamine** C12H16N4OS 17.8 265.1114 265.1118 0.4 1.4 
3 Choline (Cho)*,** C5H13NO 18.6 104.1068 104.1070 0.2 1.9 
4 Arg-Ala (RA)** C9H19N5O3 19.3 246.1570 246.1561 –0.9 –3.8 
5 Lys-Ser (KS)** C9H19N3O4 19.3 234.1434 234.1448 1.4 6.1 





C15H22N6O5S 19.6 399.1430 399.1445 1.5 3.8 
8 Ser-Arg (SR)** C9H19N5O4 19.6 262.1511 262.1510 –0.1 –0.4 
9 Ornithine (Orn)** C5H12N2O2 19.8 133.0973 133.0972 –0.1 –0.8 
10 Lysine (Lys)*,** C6H14N2O2 20.0 147.1132 147.1128 -0.4 -2.7 
11 Arginine (Arg)*,** C6H14N4O2 20.4 175.1193 175.1190 –0.3 –2.0 
12 Homolysine** C7H16N2O2 20.4 161.1287 161.1285 –0.2 –1.5 










C9H20N2O2 20.5 189.1599 189.1598 –0.1 –0.8 
16 Histidine (His)*,** C6H9N3O2 20.5 156.0774 156.0768 –0.6 –4.1 
17 Methylhistidine**  C7H11N3O2 20.7 170.0928 170.0924 –0.4 –2.3 
18 Guanidinopropanoate** C4H9N3O2 20.8 132.0761 132.0768 0.7 4.9 
19 Acetylcholine (AcCho)*,** C7H15NO2 20.8 146.1177 146.1176 –0.1 –1.0 
20 Leu-Ala (LA)** C9H18N2O3 22.0 203.1388 203.1390 0.2 1.1 
21 Cis-urocanate (cURA)** C6H6N2O2 22.2 139.0500 139.0502 0.2 1.4 
22 Guanine** C5H5N5O 22.3 152.0572 152.0567 –0.5 –3.4 
23 Carnitine (Car)*,**  C7H15NO3 22.8 162.1131 162.1125 –0.6 –3.9 
24 Trans-Urocanate (tURA)** C6H6N2O2 23.0 139.0500 139.0502 0.2 1.4 
25 Methylguanine** C6H7N5O 23.3 166.0726 166.0723 –0.3 –1.8 

















27 Acetylcarnitine (AcCar)** C9H17NO4 24.5 204.1231 204.1230 –0.1 –0.3 
28 Methylaspartate** C5H9NO4 25.4 148.0605 148.0604 –0.1 –0.4 
29 Glycine* C2H5NO2 25.3 76.0386 76.0393 0.7 9.3 
30 Niacinamide* C6H6N2O 25.4 123.0549 123.0553 0.4 3.2 
31 Creatine (CR)*,** C4H9N3O2 25.6 132.0779 132.0768 –1.1 –8.7 
32 Pro-Val (PV)** C10H18N2O3 25.8 215.1378 215.1390 1.2 5.7 
33 Alanine (Ala)* C3H7NO2 27.4 90.0548 90.0550 0.2 1.7 
34 Argininosuccinate (ASA)** C10H18N4O6 28.5 291.1292 291.1299 0.7 2.4 
35 Valine (Val)*,** C5H11NO2 30.5 118.0864 118.0863 –0.1 –1.2 
36 Serine (Ser) *,** C3H7NO3 30.6 106.0498 106.0499 0.1 0.7 
37 Isoleucine*,‡ C6H13NO2 30.7 132.1023 132.1019 –0.4 –3.0 
38 Leucine*,‡ C6H13NO2 31.0 132.1023 132.1019 –0.4 –3.0 
39 Asparagine (Asn)** C4H8N2O3 32.1 133.0610 133.0608 –0.2 –1.7 
40 Threonine (Thr)
*,** C4H9NO3 32.1 120.0654 120.0655 0.1 1.0 
41 Tryptophan (Trp)*,** C11H12N2O2 32.6 205.0967 205.0972 0.5 2.2 
42 Methionine (Met)*,** C5H11NO2S 32.7 150.0588 150.0583 –0.5 –3.2 
43 Glutamine
 (Gln)** C5H10N2O3 32.8 147.0769 147.0764 –0.5 –3.3 
44 2-Aminoadate** C6H11NO4 32.9 162.0767 162.0761 -0.6 -3.8 
45 Acetylhomoserine† C6H11NO4 32.9 162.0767 162.0761 –0.6 –3.8 
46 Citrulline (Cit)** C6H13N3O3 33.1 176.1027 176.1030 0.3 1.5 
47 Homocitrulline** C7H15N3O3 33.2 190.1178 190.1186 0.8 4.3 
48 Glutamic acid (Glu)** C5H9NO4 33.2 148.0610 148.0604 –0.6 –3.8 
49 Phenylalanine (Phe)** C9H11NO2 33.7 166.0867 166.0863 –0.4 –2.7 
50 Acetyllysine† C8H16N2O3 34.0 189.1219 189.1234 1.5 7.8 
51 Tyrosine (Tyr)*,** C9H11NO3 34.1 182.0813 182.0812 –0.1 –0.7 
52 Hypoxanthine (HPX)** C5H4N4O 34.3 137.0461 137.0458 –0.3 –2.3 
53 Proline (Pro)*,** C5H9NO2 34.6 116.0707 116.0706 –0.1 –0.8 
54 Ser-Val (SV)† C8H16N2O4 34.9 205.1181 205.1183 0.2 0.9 
55 Cysteine*,** C3H7NO2S 35.8 122.0269 122.0270 0.1 1.0 
56 Aspartic acid*,** C4H7NO4 36.0 134.0451 134.0448 –0.3 –2.4 






















59 Hydroxyproline (Hyp)** C5H9NO3 38.3 132.0660 132.0655 –0.5 –3.6 
60 Glutathione (GSH)*,** C10H17N3O6S 40.0 308.0908 308.0911 0.3 0.9 
 
Negative ion mode 
1 Arginine (Arg)** C6H14N4O2 11.3 173.1027 173.1033 0.6 3.5 
2 Lysine (Lys)** C6H14N2O2 13.9 145.0958 145.0971 1.3 9.2 
3 Glutamine (Gln)** C5H10N2O3 15.1 145.0605 145.0608 0.3 2.3 
4 Glucose*,** C6H12O6 16.4 179.0555 179.0550 –0.5 –2.8 
5 Asparagine (Asn)** C4H8N2O3 17.3 131.0461 131.0451 –1.0 –7.6 





C19H19N3O7 19.9 400.1150 400.1139 –1.1 –2.8 
8 Phosphorylcholine** C4H12NO4P 20.5 168.0413 168.042 0.7 4.3 
9 Pyridoxal** C8H9NO3 20.8 166.0519 166.0498 –2.1 –12.6 
10 Aspartic acid (Asp)** C4H7NO4 24.8 132.0287 132.0291 0.4 3.3 
11 Phosphoylethanolamine** C2H8NO4P 28.2 140.0115 140.0107 –0.8 –5.7 
12 Glyceric acid** C3H6O4 31.3 105.0191 105.0182 –0.9 –8.6 
13 Guanine** C5H5N5O 31.9 150.0415 150.041 –0.5 –3.3 
14 Pantothenic Acid** C9H17NO5 32.0 218.1044 218.1023 –2.1 –9.6 
15 
Cytidine phosphate 
(CMP)** C9H14N3O8P 38.4 322.0462 322.0434 –2.8 –8.7 
16 Adenine** C5H5N5 38.7 134.0482 134.0461 –2.1 –15.7 
17 Pyridoxic acid (PHOS)** C8H9NO4 39.7 182.0472 182.0447 –2.5 –13.7 
18 Glutamate (Glu)** C5H9NO4 40.4 146.0472 146.0456 –1.6 –11.0 
19 Uridine monophosphate**  C9H13N2O9P 40.9 323.0301 323.0274 –2.7 –8.4 
20 Hypoxanthine (HPX)** C5H4N4O 45.4 135.0311 135.0301 –1.0 –7.4 
21 Phosphocreatine** C4H10N3O5P 53.4 210.0276 210.0274 –0.2 –1.0 
22 Alanine (Ala)** C3H7NO2 53.6 88.0405 88.0393 –1.2 –13.6 
23 Guanidinopropanoate** C4H9N3O2 53.9 130.0613 130.0611 –0.2 –1.5 
24 Glucose phosphate** C6H13O9P 62.0 259.0234 259.0214 –2.0 –7.7 
        
Note: Asterisk (*) signifies identification based on migration-time. Double asterisk (**) denotes 
identification by tandem mass. Dagger (†) indicates that tandem mass spectrum agrees with molecular 
fragmentation predicted in Mass Frontier 7.0 (Thermo Fisher). Double dagger (‡) indicates mass-






Cationic and anionic measurements complemented each other. There were 
noticeable differences between CE separation performance. Fig. 3.3 presents 
representative extracted ion electropherograms for a subset of identified metabolites 
from V1 cells. Although most metabolites were separated in a shorter amount of time 
during cationic analysis, anionic separation provided higher separation efficiency: the 
average number of theoretical plates (N) was ∼170,000 for cationic and ∼200,000 for 
anionic analyses. These separation performances compare favorably to other CE-ESI 
designs, including recent low-flow coaxial (N = 15 000 plates per m)26 and sheathless 
(N = 40 000–60 000 plates per m)75 porous tip sprayer with high-sensitivity detection. 
 
 
Figure 3.3 Cationic and anionic profiling of metabolites in the same V1 cell in a live 







Additionally, metabolite identifications were also complementary (Fig. 3.4). 
Molecular assignments were made for 60 cations and 24 anions with 11 metabolites 
identified under both conditions (Fig. 3.4A). Detection performance was compared 
based on signal-to-noise (signal/noise) ratios that were calculated for these 11 
metabolites (Fig. 3.4B). The results revealed similar sensitivity for alanine, 
glutamine, glutamic acid, lysine, and pyridoxal. Cationic analysis yielded higher 
sensitivity for arginine, creatine, guanine, and hypoxanthine, whereas anionic analysis 
was more sensitive for asparagine and aspartic acid. Therefore, differences in 
complementary separation performance and compound-dependent ionization 
translated into quantitative differences using the cationic and anionic methodologies. 
 
 
Figure 3.4 Complementary (A) identification and (B) quantification of metabolites in 
single Xenopus laevis V1 cells using dual cationic–anionic microprobe CE-ESI-MS. 
Key: Cr, creatine; HPX, hypoxanthine; Pyr, pyridoxal. Reproduced from ref. 30 with 







The identified metabolites enabled pathway enrichment analysis. Metabolites 
that were identified by cationic, anionic, and dual cationic–anionic analyses were 
mapped to the KEGG metabolomic knowledgebase using MetaboAnalyst as the 
search engine (see details in Experimental). Pathway significance was calculated 
from pathway enrichment analysis, and pathway impact was determined from 
pathway topology analysis. Fig. 3.5 plots pathway significance vs. pathway impact 
from dual anionic–cationic analysis. Several pathways were enriched to statistical 
significance (p < 0.05) with pathway impact varying between high (>0.5), modest 
(0.2–0.5), and low (<0.2). Representative metabolic pathways are labeled 
in Fig. 3.5 (top panel). For example, arginine–proline and glycine–serine–threonine 
metabolism were of high impact, whereas enrichment was modest for vitamin B6 








Figure 3.5 KEGG pathway analysis for metabolites identified in single V1 cells. 
Values of statistical significance (p) and impact are shown for labeled pathways in 
Table 3.1. Pathway view for arginine–proline metabolism marking complementary 
detection by cationic and anionic analyses. ASA, argininosuccinate; Cit, citrulline; 
CR, creatine; Gly-Phos, Glycero-phospholipid metabolism; Hyp, hydroxyproline; P-
CR, phosphocreatine; SPM, spermidine; V6B, vitamin 6B metabolism. Reproduced 
from ref. 30 with permission from The Royal Society of Chemistry. 
 
 Furthermore, anionic and cationic analyses provided complementary 
information for pathway analysis. Table 3.2 compares pathway enrichment and 
pathway impact based on metabolites that were identified during the cationic, anionic, 






cover several pathways of high impact, including alanine–aspartate–glutamate, 
arginine–proline, and glutamine–glutamate. The complementarity of cationic and 
anionic detection is illustrated for the arginine–proline pathway in Fig. 3.5 (bottom 
panel). Notably, additional metabolite identifications that resulted from dual cationic–
anionic analysis helped improve statistical significance and/or pathway impact for 
several pathways, including glycerophospholipid and vitamin B6 metabolism (see 
Table 3.2). Combined, these results demonstrate that dual cationic–anionic analysis 
by microprobe single-cell CE-ESI-MS provide deeper coverage of metabolism than 
feasible by these approaches in isolation. 
 
Table 3.2 KEGG pathway analysis (statistical p-value and pathway impact) for 





Cationic Analysis Anionic Analysis Dual Analysis 




24 7 1.06E-05 0.74 5 3.24E-05 0.60 7 4.34E-05 0.74 
Arginine, 
proline 
43 12 7.33E-09 0.54 7 3.57E-06 0.23 13 8.17E-09 0.54 
Glutamine, 
glutamate 
5 2 1.12E-02 1.00 2 2.27E-03 1.00 2 1.75E-02 1.00 
Glutathione 26 7 1.91E-05 0.46 1 0.36 0.03 7 7.69E-05 0.46 
Glycero-
phospholipid 




31 7 6.66E-05 0.57 2 0.10 0.00 8 3.14E-05 0.57 
Histidine 14 4 1.12E-3 0.24 2 2.26E-02 0.00 4 2.25E-03 0.24 








13 4 8.21E-04 1.00 0 0 0.00 4 8.21E-04 1.00 








In this study, we advanced CE-ESI-MS technology to enable dual cationic–
anionic analysis of metabolites in single embryonic cells. In situ microprobe sampling 
using a microfabricated capillary allowed us to sample an identified cell directly in a 
live X. laevis embryo under optical guidance by a stereomicroscope. To analyze 
metabolites extracted from the collected cell content, we equipped an in-house built 
CE-ESI-MS12 platform with dual capability to perform cationic and anionic analysis 
using different BGEs for separation, without modifying the setup between sequential 
measurements. Optimization of experimental variables and the use of a nitrogen bath 
gas to minimize/eliminate electrical breakdown upon negative electrospray ensured 
sufficiently reproducible and robust operation for single-cell investigations in trace 
sensitivity (∼5 nM, viz. ∼50 amol demonstrated here). 
 The approach affords analytical benefits for biological studies on single cells. 
In situ microprobe sampling is compatible with complex tissues and organisms, as we 
demonstrated for 8-cell embryos of X. laevis in this work. CE-ESI-MS consumes 
sufficiently small amounts of extracts to afford multiple analysis of the same extract 
under cationic and anionic conditions. With complementary performance, the 
metadata resulting from these approaches improved metabolite identifications and 
quantification, which in turn led to better coverage of metabolic networks in single 
cells. This study design complements earlier works in which bare fused or coated 
capillaries were used to deepen metabolic coverage. Further improvements in 
detection sensitivity and expansion of metabolomic MS–MS/MS databases are 






cells. Combined, results from this study and recent works12, 55, 100, 112 suggest that dual 
cationic–anionic microprobe CE-ESI-MS is scalable to smaller cells and other types 










Chapter 4: Uncovering metabolic pathways underlying cell 
fate commitment during early embryonic development   
 
 
Based on material in preparation for submission by Erika P. Portero, Aleena J. 
Andrews, and Peter Nemes*.  
4.1 Introduction 
The study of molecular mechanisms underlying cell and tissue differentiation 
is essential to enhance our understanding of normal and impaired development. 
Characterization of the biochemical state of individual cells in the organism provides 
a powerful descriptor of cell heterogeneity,64, 143 as a single-cell differentiates to form 
specific tissues and organs. For example, emerging information from human, mouse, 
and frog (X. laevis) embryonic stem cells suggests the implication of metabolic 
reactions during key developmental processes including cell differentiation,144-146 cell 
fate commitment,12 morphogenesis, and organ formation.147-148 In fact, the 
metabolome provides fast and dynamic feedback to intrinsic and extrinsic events, 
offering a unique look into the phenotypical and physiological state of the cell.64 
Mass spectrometry (MS) offers unbiased label-free detection and quantitation of 
metabolites with high sensitivity and selectivity. Particularly, single-cell MS provides 
a significant improvement over contemporary large-scale cell pooling analysis since it 
eliminates signal averaging that can interfere with the identification of cell-to-cell 
variability. 
A subset of single-cell MS technologies utilizes chemical separation prior to 






coverage of the single-cell metabolome.12, 29, 55, 70, 149-150 By combining cell dissection, 
microprobe sampling, and single-cell CE-ESI-MS, the Nemes lab recently revealed 
spatial and temporal metabolic heterogeneity among single cells of the X. laevis 
embryo,12, 55, 57 and uncovered metabolites that can alter dorsal–ventral cell 
commitment.12 Although dorsal and ventral cell types in the 16-cell embryo present 
characteristic metabolic profiles; the fundamental molecular mechanisms that link 
metabolites and cell fate commitment remain unspecified. 
To help address this knowledge gap, I applied a stable isotope labeling (SIL) 
approach to elucidate dynamic metabolism in developing embryonic cells of the 
Xenopus laevis. Stable isotope labeling has demonstrated to be a useful tool to study 
metabolic flux and pathway discovery in systems biology.151-153 Since metabolic 
fluxes are considered an endpoint of cellular regulation and are likely to reflect 
changes on the transcriptome and proteome, it has become a valuable read-out in 
many areas of biology, including biomedicine and bioengineering.154-155 Isotopic 
labeling patterns are also known to be a direct consequence of metabolic fluxes; thus, 
changes in labeling pattern indicate metabolic flux changes. The use of isotope tracers 
(e.g., 13C-glucose, 13C-amino acids, etc.) provides valuable information on the 
dynamics of downstream metabolite labeling, enabling the study of metabolic 
pathways. Recently, stable isotope labeling and liquid chromatography (LC)-MS on 
whole X. laevis embryos revealed the remodeling of core metabolic pathways during 
early cleavage stages by tracking the consumption of neutron-enriched (heavy 
labeled) alanine and aspartate in the Krebs cycle.13 However, the analysis of whole 






alanine, proline) between embryos, emphasizing the importance of a single-cell 
analysis to avoid embryo-to-embryo variability. 
This chapter describes the development of a single-cell metabolomics 
workflow combining stable isotope labeling and microprobe CE-ESI-MS to uncover 
dynamic metabolic pathways from targeted dorsal and ventral offspring cells, also 
referred to as clones, at the early stages of embryonic development. This strategy 
investigates metabolism of dorsal and ventral clones from the 16-cell stage to stage 9 
at the mid-blastula transition. Next, I applied this approach to identify temporal 
changes of the metabolome of dorsal and ventral clones after microinjecting select 
metabolites known to alter cell fate commitment in the 16-cell X. laevis embryo. The 
presented work identified metabolic pathways that respond to metabolite 
concentration changes, and the rapid rearrangement of the metabolome that ultimately 
leads to tissue fate alterations of dorsal and ventral clones. 
4.2 Experimental 
4.2.1 Chemicals and reagents  
 
 Chemicals. LC-MS-grade solvents including acetonitrile, methanol, and water 
as well as formic acid, phosphate buffered saline (PBS, 10X) solution, and Alexa 
Fluor Dextran 488 (FD) were purchased from Fisher Scientific (Fair Lawn, NJ). 
Ficoll PM 400, 13C4,15N-L-threonine (Thr*), and 13C5,15N-L-methionine (Met*) 
were from Sigma-Aldrich (Saint Louis, MO). L-methionine (Met), L-serine (Ser), D-
threonine (Thr), and acetylcholine chloride (ACh) were from Acros Organics (Fair 






from MP Biomedicals (Solon, OH). Capillaries. For sample collection, borosilicate 
capillaries (0.5/1.0 mm inner/outer diameter, part no. B100-50-10, Sutter Instrument 
Co., Novato, CA) were pulled to barrel length ~800 µm in a capillary puller ( model 
P-1000, Sutter Instruments Co., Novato, CA). For capillary electrophoresis (CE), 
fused silica capillaries (40/104 µm inner/outer diameter) were from Polymicro 
Technologies, Phoenix, AZ and used as received. CE capillaries were conditioned 
prior to use with 100 mM sodium hydroxide. As the emitter for electrospray source, a 
platinum alloy emitter (0.0055” inner diameter and 0.003” wall, part no. 29910E, 
Johnson Matthey Inc., West Chester, PA) was used. GFP Plasmid and mRNA. In 
vitro transcription kit (part no. AM1348, ThermoFisher Scientific, Waltham, MA) 
and plasmid containing open-reading frame for green fluorescent protein (pCS2+). 
4.2.2 Solutions  
 Biology. Steinberg’s solution (SS), 2% cysteine, 3% Ficoll, and 4% 
paraformaldehyde in PBS solutions were prepared following standard protocols.126 
All solutions and media that were used to culture embryos or to perform cell 
injections were prepared with DEPC-treated and autoclave-sterilized deionized. Cell 
fates were traced using 0.5% (v/v) FD in DEPC-treated water. Chemistry. The 
metabolite “extraction solvent” comprised of 40% acetonitrile and 40% methanol in 
LC-MS grade water (pH 4.7), chilled at 4 °C, chosen to stabilize the metabolome by 
minimizing/eliminating metabolic degradation.12, 57, 100 For CE, the background 






“sheath liquid” was 0.1% formic acid in 50% methanol prepared in LC-MS grade 
water. 
4.2.3 Animals and embryo collection 
 All protocols related to the maintenance and humane handling of animals 
were approved by the University of Maryland Institutional Animal Care and Use 
Committee (IACUC no. R-DEC-17-57). Adult male and female Xenopus laevis frogs 
were purchased from Nasco (Fort Atkinson, WI) and maintained in a breeding 
colony. Fertilized embryos were obtained via gonadotropin-induced natural mating of 
adult frogs. The jelly coating surrounding freshly laid embryos was removed using a 
2% cysteine solution following established protocols.126 Dejellied embryos were 
transferred to Petri dishes containing 100% SS and examined under a 
stereomicroscope. To enable accurate cell type identification in this study, 2-cell 
embryos showing stereotypical pigmentation patterns134 across the left-right axis were 
isolated into a separate Petri dish and cultured in 100% SS at 21 °C temperature. 
Developmental staging followed the Nieuwkoop-Faber156 nomenclature.  
4.2.4 Cell fate tracking and metabolite injections 
 Individual 2-cell X. laevis embryos were monitored under a stereomicroscope 
until they reached the 16-cell stage, then transferred to a Petri dish containing 3% 
ficoll in 100% SS. In the 16-cell embryo, the midline dorsal-animal (D11) and the 
midline ventral-animal (V11) cells were identified following established cell fate 
maps.58, 135 As controls in this study, the dorsal and ventral cell clones were labeled 






D11 cells (N = 78) or the left V11 cells (N = 44) were injected with 2 nL of 100 
pg/nL GFP mRNA using a microinjector station. A microscope (model SMZ 1270, 
Nikon, Melville, NY) was employed to identify the cell type and position using a 
three-axis micromanipulator (TransferMan 4r, Eppendorf, Hauppauge, NY ) the tip of 
the pulled borosilicate capillary (~10 µm inner diameter) into the cell. The capillary 
was connected to a microinjector (model PLI-100A, Warner Instrument, Handem, 
CT) delivering a pressure pulse (40 psi for 0.9 s), which in turn delivered the required 
volume.157 
The experimental groups consisted of metabolite-perturbed clones of D11 and 
V11. To study the effect of metabolites on the dorsal clone, the identified D11 cell 
was injected with 2 nL of metabolite mixture of the following composition in DEPC-
treated water: 7.5 mM ACh and 100 pg/nL GFP mRNA (N = 81); 75 mM Met and 
100 pg/nL GFP mRNA (N = 72); 7.5 mM ACh, 75 mM Met, and 100 pg/nL GFP 
mRNA (N = 91); or 40 mM Thr* with 100 pg/nL GFP mRNA (N = 67). Similarly, 
the effect of metabolite perturbation was evaluated on the ventral clone by injecting 
the identified V11 cell with 2 nL of metabolite mixture containing following: 75 mM 
Thr and 100 pg/nL GFP mRNA (N = 49); 75 mM Ser and 100 pg/nL GFP mRNA (N 
= 57); 75 mM Thr, 75 mM Ser, and 100 pg/nL GFP mRNA (N = 61); or 60 mM Met* 
and 100 pg/nL GFP mRNA (N = 49). Approximately 20 min after the injection, the 
embryos were transferred into Petri dishes containing 50% SS and cultured at 14 °C 
to the larval stage. Stage 34 larvae were fixed in 4% paraformaldehyde and 3% 
sucrose in PBS for 1 h. The fixed larvae were rinsed with 1× PBS and stored at 4 °C 







 The larvae were imaged under bright-field and epifluorescence on a research-
grade stereomicroscope (model SMZ18 equipped with SMZ-25/18 P2-EFLC EGFP 
BP HC Filter Set, Nikon, Melville, NY). The relative size of the cell clones in each 
tissue of interest were assessed in stage 34 larvae following established cell fate 
maps.58, 135 Criteria for scoring were as follows: “0” was assigned to mark no labeled 
cells in the tissues of interest; “1” was assigned to indicate ≤ 10 labeled cells in the 
tissue of interest; “5” was assigned when at least 50% of the cells in the tissue were 
labeled; and “10” was assigned for tissues entirely labeled by fluorescent cells. To 
eliminate inter-personal biases during scoring, the same person performed all the 
phenotyping through this study. 
4.2.6 Stable isotope labeling of dorsal and ventral clones 
 Metabolic perturbation as dorsal-ventral clones switched tissue fate was 
reported using an isotopologue of endogenously enriched threonine in the D11 cell 
and methionine in the V11 cell, viz. in the 16-cell embryo. To enhance detection 
sensitivity by allowing for metabolic incorporation, the precursor cell of the clone 
was injected with the heavy isotope at an early stage, viz. at the 4-cell stage. After 
culturing the embryo to the 16-cell stage in 3% Ficoll in 100% SS, metabolic 
perturbation was introduced with co-injection into the cell with the dye FD. 
Therefore, to study dorsal-to-ventral fate change in the D11 cell upon Met injection, 
the left D cell (4-cell embryo) was injected with 2 nL of 40 mM Thr* and the 






FD). Conversely, to study ventral-to-dorsal fate change in the V11 cell upon Thr 
injection, the left V cell (4-cell embryo) was injected with 2 nL of 60 mM Met*, and 
the offspring left V11 cell was injected with 2 nL Thr and FD (75 mM Thr in 0.5% 
FD). The resulting embryos were cultured at room temperature in 50% SS to the 
cleavage (32 or 64 cells) or blastula (stages 8 or 9) stages. 
4.2.7 Sample preparation 
 The fluorescently labeled clones (FD) were visualized under the fluorescence 
stereomicroscope. The sample collection (sampling) approach was tailored to 
corresponding developmental stages. In the cleavage stage embryos (32- and 64-cell), 
where cells are considerably large, an ~10–15 nL volume of the D11 (N = 3) or V11 
(N = 3) clone were aspirated using a fabricated microprobe (~20 µm outer diameter) 
following our established protocol.55, 101 Metabolites from the collected cell content 
were extracted in 4 µL of metabolite extraction solvent (4 °C) in a microvial. The 
microprobe was replaced for each sampling event to avoid cross-contamination. For 
mid-blastula stage 8 (N = 3) or stage 9 (N = 3), the protective vitelline membrane was 
carefully peeled off and the fluorescent clones dissected using sharp forceps under 
guidance by the stereomicroscope.12 Metabolites were extracted from the collected 
tissues in 10 µL of metabolite extraction solvent (4 °C). Vials containing the cell 
extracts from the cleave- and blastula-stage embryos were vortex-mixed for ~1 min at 
room temperature to facilitate lysis and extraction and centrifuged for 5 min at 8,000 
× g at 4 °C to pellet cell debris. The resulting extracts were kept together with the cell 






4.2.8 CE-ESI-MS platform 
 Metabolite extracts were analyzed using a home-built microanalytical CE 
electrospray ionization (ESI) platform coupled to a commercial high-resolution mass 
spectrometer (HRMS; Impact HD, Bruker Daltonics, Billerica, MA). Details of the 
experimental setup12, 100 as well as protocols of operation and performance 
validation101 were described elsewhere. Experimental settings were optimized for 
separating metabolites by CE (capillary, 1 m and 40/105 µm inner/outer diameter; 
potential on inlet end, +18–20 kV dynamically adjusted to maintain ~7.5–8.0 µA 
current across the fused silica capillary) and ionizing them in a co-axial sheath flow 
CE-ESI interface (flow rate of sheath liquid, 0.6 µL/min; design, earth grounded; 
spray regime, coaxial for optimal ionization efficiency. The generated ions were 
mass-analyzed on a quadruple orthogonal-acceleration time-of-flight HRMS with the 
following settings: spray voltage, –1,700 V (applied to orifice front plate); MS survey 
scan rate, 2 Hz; mass range (MS1 and MS2), m/z 50–550; collision-induced 
dissociation, 18–20 eV in nitrogen collision gas; dry gas, 2 L/min at 100 °C. The 
mass spectrometer was externally mass calibrated on a bi-daily basis to <0.6 ppm 
mass (m/z) accuracy using sodium formate clusters that formed as sodium ions of 
abundance in the sample migrated into the ion source. 
4.2.9 Data analysis 
Primary HRMS–MS/MS data were processed in Compass DataAnalysis 
version 4.3 (Bruker Daltonics) following our established protocols.12 Each data file 






formate clusters. A custom-written script was used to generate extracted ion 
chromatograms (EICs) for identified metabolites and their [M+1] isotopes within ±5 
mDa accuracy. Peak intensities and the under-the-curve peak areas were manually 
integrated. Precise masses (m/z values) were calculated in Compass IsotopePattern 
(Bruker Daltonics version 4.3). Isotope ratios (%) were normalized to the 
monoisotopic peak. Metabolic pathway analysis was conducted in MetaboAnalyst 
4.0120 with the following settings: pathway library, Danio rerio (zebrafish) model; 
pathway analysis algorithm, overrepresentation analysis by hypergeometric test, and 
pathway topology by relative betweenness centrality. Pathway mapping was 
performed using Kyoto Encyclopedia of Genes and Genomes (KEGG).158 Statistics. 
The metadata were normalized by total sum and further evaluated in MetaboAnalyst 
4.0 using Euclidian method to calculate the distance matrix and Ward method to 
generate data clusters for hierarchical cluster analysis. One-way ANOVA was 
measured at p-value <0.05 to determine statistical significance and post-hoc tests 
using Fisher’s least significant discriminant (LSD). Two-tailed Mann-Whitney U test 
was calculated in OriginPro 2016 (OriginLab, Northampton, MA) with p ≤ 0.05 
marking significance.   
4.3 Results and discussion 
4.3.1 Altering the concentration of individual metabolites results in cell fate changes 
 A recent study uncovered differences in metabolite levels among three cell 
types on the 16-cell X. laevis embryo located in the dorsal–ventral and animal–






established cell fate maps,58, 134 each targeted cell has a predetermined cell fate 
leading to the formation of specific tissues. For example, the midline dorsal-animal 
D11 cell gives rise to the brain, retina, and central somite, whereas the midline 
ventral-animal V11 cell gives rise to the head and trunk epidermis (Fig. 4.1). 
Although single-cell MS was able to capture metabolite abundance differences 
between D11 and V11 cells, further experiments revealed the developmental 
significance of cell-specific metabolite profiles in determining cell fates. 
Interestingly, it was found that injecting a subset of metabolite standards into dorsal 
D11 or ventral V11 cells influences their corresponding tissue fates. For example, 
microinjecting a mixture of metabolite standards that were quantified as largely 
abundant in the V11 cell (e.g., acetylcholine and methionine) along with a fluorescent 
lineage tracer into the D11 cell (Fig. 4.1A) showed a reduction in the fluorescent 
labeling of neural tissues such as the brain and central somite. Consequently, a 
substantial increment of fluorescently labeled cells that corresponded to head and 
body epidermis was noticed. Likewise, microinjecting metabolites found in higher 
concentrations in the D11 cell (e.g., serine and threonine) into the V11 cell (Fig. 
4.1B) revealed the establishment of neural tissues such as the retina and cement 
gland. Although it was previously demonstrated that altering the concentration of a  
mixture of metabolites in dorsal and ventral cells has an effect on tissue fate, as the 
metabolome reacts rapidly to intrinsic and external factors such as concentration 
variations due to cellular actions;150 we anticipated that altering the concentration of 







Figure 4.1 Metabolite microinjections and cell linage tracing at larval stages (side 
view) to test metabolite-induced cell fate changes. (A) D11 cells were injected with 
GFP mRNA only as control, GFP mRNA plus a mixture of acetylcholine and 
methionine (A+M), and GFP mRNA with acetylcholine (A) or methionine (M). 
Fluorescent D11 descendant cells corresponding to central somite (Cs), cement gland 
(CGland), and epidermis (Epi) are observed. (B) V11 cells were injected with GFP 
mRNA only as control, GFP mRNA plus a mixture of serine and threonine (S+T), 
and GFP mRNA with serine (S) or threonine (T). Fluorescently labeled descendant 
cells of the V11 corresponding to retina and olfactory placode (Olf) were observed. 
Scale bar = 300 µm. 
 
 
 To compare the effect of individual metabolite injections to the cell fate of the 






the experimental section. Acetylcholine and methionine chemical standards were 
microinjected into D11 cells as a mixture (n = 91) and individually (n = 81 and n = 
72, respectively) along with a fluorescent lineage tracer to help with the identification 
of the clone at the larval stage. Additionally, a subset of D11 cells were microinjected 
with lineage tracer only (n = 78) to serve as a control. We conducted lineage analysis 
at the larval stage (stage 34) by determining the relative contribution of fluorescent 
cells to the organ/tissue fate as described elsewhere.134-135 As observed in our 
previous study,12 the injection of acetylcholine and methionine mixture into the D11 
cell (Fig. 4.1A) shows a significant decrease in the fluorescent labeling of the brain 
and central somite, and an increase of epidermal cells as compared to the control 
larvae injected with lineage tracer only. Remarkably, individual injections of 
acetylcholine and methionine also showed a significant reduction in the formation of 
neural structures (Appendix 4.1). For example, the injection of acetylcholine revealed 
a substantial effect on the formation of the brain (Mann-Whitney U = 4180, p < 
0.0005) as compared to the injection of the metabolite mixture (Mann-Whitney U = 
4586, p = 0.0006). Likewise, injecting methionine in the D11 showed a significant 
decrease on the formation of the lens and olfactory placode than observed with the 
metabolite mixture (Mann-Whitney U= 3372, p = 0.02 and p = 0.06). Additionally, 
we microinjected serine and threonine as a mixture (n = 61) and individually (n = 57 
and n = 49, respectively) into V11 cells and uncovered a significant formation of the 
retina with discrete metabolite microinjections (Mann-Whitney (mixture) U = 1004,  
p = 0.01 and (threonine) U= 696 , p < 0.0005). Thus, we find that altering the 






of X. laevis embryonic cells that lead to changes in tissue fate. Supporting this notion, 
it is well-known that metabolite concentrations are essential to regulate cellular 
processes such as reaction rates159 and enzyme binding160 that influence the dynamic 
state of the metabolome. 
4.3.2 Tracking dynamic metabolic pathways of early developing clones 
 To investigate the effect of metabolite-injections that alter the metabolism of 
dorsal and ventral cells, we developed a stable isotope labeling strategy compatible 
with the live developing X. laevis embryo. Using isotope tracers, we sought out to 
investigate downstream metabolite labeling patterns to elucidate dynamic metabolic 
pathways. First, we selected isotope tracers based on previous knowledge of the D11 
and V11 cell metabolome.12 For example, single-cell MS measurements found 
threonine to be highly enriched in the D11 cell as compared to the V11, raising the 
possibility of a fast turnover of threonine in dorsal clones. First, we tested the 
incorporation of heavy isotope threonine (13C4,15N-L-threonine or Thr* ) by injecting 
the dorsal-left cell in the 4-cell embryo, when the dorsal–ventral developmental axis 
is established, and microsampling a portion of the D11 cell in the 16-cell embryo. 
Single-cell CE-ESI-MS analysis of control and Thr* injected D11 cells identified fast 
incorporation of 13C and 15N by comparing experimental and theoretical percent 
isotope abundance of the M+1 signal for a subset of previously identified metabolites. 
Based on the fast incorporation of threonine isotope tracer, with ~30–40 min of 
developmental time between the 4- to 16-cell X. laevis embryo161 at room 






labeling patterns during cleavage and blastula stages (Fig. 4.2).  Additionally, we 
selected heavy isotope methionine (13C5,15N-L-methionine or Met*) as an isotope 
tracer for the ventral clone, since methionine has been previously detected in high 
abundance in the V11 cell.12  
 
Figure 4.2 Stable isotope labeling workflow to investigate metabolic pathways 
involved in metabolite-induced cell fate alteration in early developing dorsal and 
ventral clones of X. laevis. Thr* was injected into dorsal cells and Met* into ventral 
cells with fluorescent dye (FD), followed by single-cell CE-ESI-HRMS workflow. 
Scale bar = 250 µm   
 
 The overall stable isotope labeling approach to track metabolic pathways that 
participate in dorsal and ventral cell fate specification is presented in Fig. 4.2. To 
investigate a dorsal-to-ventral cell fate change (Fig. 4.2A), we injected the dorsal-left 






methionine was injected to alter the D11 cell fate. A fluorescent dye was co-injected 
into the D11 cell to facilitate cell-clone tracking and targeted sampling, as cell 
division becomes asymmetrical and less synchronized during blastula stages.162 Using 
our recently developed microprobe sampling approach,55 we collected ~ 10–15 nL of 
cellular content from offspring cells of the D11 at the 32- and 64-cell stage, and 
conducted cell-dissection of fluorescent dorsal clones at stages 8 and 9. For each 
developmental stage, n = 3–4 biological replicates were collected to ensure statistical 
confidence. To track native metabolism of dorsal clones, a control group was 
collected (n = 3 biological replicates per stage) comprising of dorsal clones without 
methionine injections. We applied the same approach to track ventral-to-dorsal cell 
fate change (Fig. 4.2A); however, the ventral-left cell was injected with a heavy 
isotope methionine tracer, and threonine at the 16-cell embryo to alter V11 cell fate (n 
= 3–4 biological replicates). A control group for ventral clones was collected in n = 3 
biological replicates per stage. A detailed report of heavy isotope metabolite tracer 
injections, cell sampling and single-cell CE-ESI-MS analysis is provided in the 
methods. 
 We calculated the percent isotope abundance of the M+1 signal for a subset of 
~70 previously identified metabolites (Appendix 4.2). Metabolites that exhibited 
significantly higher M+1 signal abundance as compared to theoretical values derived 
from each metabolite chemical formula, were considered to have incorporated 13C 
and 15N from heavy isotope tracers. These metabolites were mapped to the Kyoto 
Encyclopedia of Genes and Genomes (KEGG),158 a metabolomic knowledgebase to 






pathway impact calculated from pathway topology analysis (Figure 4.3).  
Interestingly, several pathways were enriched with high significance (p < 0.005), 
including arginine–proline metabolism, which has been identified in early cleavage X. 
laevis embryos.30, 57 Moreover, metabolism of threonine isotope tracer in the dorsal 
clone identified the arginine–proline and glutathione metabolisms as statistically 
significant with a high pathway impact. However, when methionine was injected in 
the D11 cell, the isotope labeling pattern revealed a significant enrichment of the 
valine–leucine–isoleucine metabolism (Figure 4.3A) in the dorsal clone. Recent 
studies have documented the correlation between branched chain amino acids (e.g., 
leucine, glutamine, and isoleucine) and the (mammalian target of rapamycin) mTOR 
signaling pathway,163 largely known to serve as a regulator of cell metabolism, 
proliferation, development, and survival.164 Although it is unclear whether amino 
acids are able to activate mTOR, protein kinases have been identified as mediators of 
amino acid signaling to induce mTOR in stem cells.165-166 Additionally, metabolism 
of the methionine isotope tracer in the ventral clone reveled arginine–proline and 
alanine–aspartate–glutamate metabolisms as statistically significant; but after 
injecting threonine into the V11 cell (Figure 4.3B), the labeling pattern exhibited 
enrichment of the glutathione metabolism. This is consistent with recent findings 
indicating the importance of redox regulation during early embryonic cell 
differentiation.144 For example, glutathione (GSH) serves as a reducing agent that 
protects the cell from oxidative stress/damage by converting to its oxidized form 






oxidized-glutathione (GSSG) form; thus, we hypothesize that the glutathione 
metabolism is activated to maintain homeostasis. 
 
Figure 4.3 KEGG pathway analysis of (A) dorsal cell clones injected with 13C4,15N-
L-threonine and dorsal clones injected with Thr* and methionine. (B) Ventral clones 
injected with 13C5,15N-L-methionine (or Met*), and ventral clones injected with Met* 







4.3.3 Effect of isotope tracer injections to embryonic development 
 Since altering the inherent metabolite abundance of D11 and V11 cells causes 
changes to tissue fate, we tested whether injection of isotope tracers leads to cell fate 
changes (Fig. 4.4). For instance, threonine was measured at 10 pmol and found to be 
significantly abundant in the D11 cell as compared to the V11 cell;12 however, we 
microinjected its isotope tracer equivalent (13C4,15N-L-threonine) in a fourfold (×4) 
quantity at 40 pmol. Similarly, methionine was measured at 20 pmol in the V11 cell 
and its isotope tracer equivalent (13C5,15N-L-methionine) was injected into the ventral 
cell in a threefold (×3) concentration at 60 pmol (see experimental methods). Lineage 
analysis at the larval stage revealed statistical differences (Mann-Whitney U = 2628, 
p = 0.0192) in the formation of the olfactory placode, between control (n = 72) and 
heavy-isotope threonine injected (n = 67) D11 cells. In ventral cells, lineage and 
statistical analysis revealed no differences between control (n = 70) and heavy-






       
Figure 4.4 Injection of isotopically labeled metabolites and cell lineage tracing in X. 
laevis embryos. Scale bar = 300 µm. 
 
4.3.4 Single-cell metabolome reorganizes during cell fate commitment 
 Metabolite profiles of control and metabolite-injected dorsal and ventral 
clones were compared using multivariate analysis. Unsupervised hierarchical cluster 
analysis (HCA) and heat map (Fig. 4.5) analysis were performed based on 60 
commonly identified metabolites and 20 corresponding M+1 signals among dorsal 
and ventral clones. The relative abundance of each signal was computed by 
integrating the under-the-curve peak area of extracted ion electropherograms. The 
resulting dendrogram shows the clustering of all samples into four main groups (Fig. 
4.5, Top axis), each corresponding to different experimental conditions: dorsal clone 






clone injected with threonine. Sub-clustering of each group reveals that cleavage (32- 
and 64-cell) and blastula stages (stages 8 and 9) are comprised of different metabolite 
abundances. In support of this view, a previous study conducted on single dorsal-cells 
of the 16- and 32-cell X. laevis embryo revealed a subset of metabolites (e.g., 
creatine, lysine, arginine) that maintain similar abundance levels in the cleavage 
stages.55 Likewise, a study on whole X. laevis embryos confirmed the increase of 
select metabolites (e.g., glutamine, α-ketoglutarate) during blastula stages as part of 
the tricarboxylic acid (TCA) cycle.13 Based on these observations, it is possible that 
the sub-clustering observed in our data reflects metabolic changes between cleavage 
and blastula stages. 
 We also identified differential clustering of metabolite abundance among 
experimental conditions (Fig. 4.5, Top axis) resulting in two subgroups. Surprisingly, 
the left group consisted of samples collected from ventral cells and methionine-
injected dorsal cells, revealing a small subset of metabolites (Fig. 4.5, Left axis, 
bottom) found in high abundance between the two groups. After injecting methionine 
into the D11 cell in the 16-cell embryo, it appears that the metabolome of its offspring 
cells (32-cell to stage 9) adjusts rapidly to the perturbation in metabolite 
concentration. In this case, the metabolite composition of methionine-injected dorsal 
clones becomes similar to the ventral clone. Similarly, the right group (Fig. 4.5, Top 
axis) contains samples collected from dorsal cells and threonine-injected ventral cells; 
suggesting that the metabolome of dorsal and ventral clones injected with metabolite 
standards to alter cell fate commitment rapidly reorganizes to replicate the metabolic 







Figure 4.5 Hierarchical cluster analysis- heat map of metabolites detected in dorsal 
and ventral clones. (Top) Experimental and control groups, (Right) metabolite 
identifiers, (Left) clustering, and (Bottom) sample-stage identifiers. Metabolite 
abundance was normalized to the total sum. 
 
Although stable isotope labeling was able to capture differences in metabolic 
pathway activity during metabolite-induced cell fate changes, a secondary effect in 






approach. Isotope labeling patterns are directly associated to metabolic pathways that 
utilize (deplete) the isotope tracer introduced into the organism. Thus, all downstream 
changes in metabolism would hardly participate in isotope labeling patterns alone; 
instead there are additional resulting widespread alterations to the metabolome. 
Analysis of variances (ANOVA) uncovered a subset of 30 metabolites (Table 4.1) 
with statistically different abundance levels among the four experimental groups (Fig. 
4.5, Top). For instance, there is a significant increase in the relative abundance of 
aspartate, glutathione, and hypoxanthine in metabolite-injected clones. Unexpectedly, 
the increase in aspartate concentration during early embryonic development 
contradicts previous isotope-flux experiments in whole X. laevis embryos13 and 
single-cell metabolic profiling of D11 offspring cells.55 Recent experiments identified 
alanine as an energy source that rapidly converts to aspartate in early developing X. 
laevis embryos, which acts as a source of nitrogen to produce glutamine and other 
nucleotides for the embryo. In agreement with the notion that consumption-
production of aspartate and glutamine are interconnected, we observed a decrease in 
glutamine abundance after the injection of metabolites that lead to cell fate changes. 
The change in production of aspartate suggests a significant shift in the Ala–Asp–Glu 
pathway, indicating the activation of other metabolic networks including the Cys–Met 









Table 4.1 Metabolite abundance changes calculated by one-way ANOVA between 
dorsal and ventral clones injected with heavy-isotope tracers and metabolites to alter 
cell fates. Key: F value, ratio of variance; FDR, false discovery rate. 
 
ID Metabolite  F value p value FDR 
1 2-Aminoadate 4.64 6.45E-03 1.16E-02 
2 Acetylcarnitine 4.09 1.18E-02 1.89E-02 
3 Acetylcholine 12.27 5.03E-06 2.79E-05 
4 Arginine 13.72 1.59E-06 1.04E-05 
5 Arginine [+1] 9.76 4.24E-05 1.72E-04 
6 Asparagine 7.47 3.56E-04 1.03E-03 
7 Asparagine [+1] 8.07 2.00E-04 6.41E-04 
8 Aspartate 12.06 6.00E-06 3.05E-05 
9 Carnitine 5.55 2.46E-03 5.00E-03 
10 Creatine 4.36 8.79E-03 1.53E-02 
11 Glutamate 4.32 9.16E-03 1.55E-02 
12 Glutamate [+1] 6.58 8.58E-04 2.09E-03 
13 Glutamine 8.54 1.29E-04 4.93E-04 
14 Glutamine [+1] 7.08 5.23E-04 1.39E-03 
15 Glutathione 13.64 1.70E-06 1.04E-05 
16 Guanine 5.26 3.34E-03 6.36E-03 
17 Guanine [+1] 6.67 7.85E-04 1.99E-03 
18 Histidine 14.52 8.65E-07 6.59E-06 
19 Homolysine 8.27 1.66E-04 5.92E-04 
20 Hypoxanthine 18.68 4.58E-08 5.58E-07 
21 Hypoxanthine [+1] 14.92 6.41E-07 5.59E-06 
22 Leucine 6.52 9.12E-04 2.14E-03 
23 Methionine 46.05 6.68E-14 2.04E-12 
24 Methyl- aspartate 15.42 4.45E-07 4.52E-06 
25 Methyl- histamine 47.51 3.91E-14 2.04E-12 
26 Phenylalanine 6.18 1.29E-03 2.70E-03 
27 Proline 10.30 2.65E-05 1.16E-04 
28 Proline [+1] 11.94 6.62E-06 3.11E-05 
29 Putrescine 5.52 2.54E-03 5.00E-03 
30 Pyridoxal 7.50 3.44E-04 1.03E-03 
31 SAM 6.26 1.18E-03 2.57E-03 
32 Ser-Arg 4.29 9.44E-03 1.56E-02 
33 Serine 7.30 4.21E-04 1.17E-03 
34 Spermidine 8.22 1.75E-04 5.92E-04 
35 Spermidine [+1] 5.03 4.25E-03 7.86E-03 
36 Tryptophan 6.33 1.10E-03 2.48E-03 
37 Tyrosine 21.35 8.26E-09 1.68E-07 






Next, we mapped our data comprising of isotopically-labeled metabolites, and 
metabolites identified to change abundance levels using ANOVA to the KEGG 
database. The results showed a high coverage of the following metabolic pathways: 
Arg–Pro, Gly–Ser–Thr, Cys–Met, Ala–Asp–Glu and glutathione metabolism. Fig. 4.6 
shows a reconstructed metabolic network containing the formerly identified 
metabolic pathways. Several metabolites exhibit a direct relation to the injected 
isotope tracers. For example, isoleucine, tyrosine, γ-aminobutyric acid (GABA), and 
carnitine showed incorporation of heavy isotope 13C or 15N after the injection of 
methionine into the D11 cell to cause a shift from dorsal-to-ventral cell fate. 
Additionally, metabolites such as leucine and glutamine presented both heavy isotope 
incorporation and significant changes in abundance based on ANOVA. Moreover, a 
subgroup of metabolites including aspartate, phenylalanine, proline, S-
adenosylmethionine, and acetylcarnitine were identified to significantly vary in 
abundance levels after injection of methionine into the D11 cell. Intriguingly, the 
latter two metabolites were found to be accumulated in the dorsal clone after injection 
of methionine; however, previous studies reported their enrichment in ventral cells in 
the 16-cell X. laevis embryo12 with acetylcarnitine decreasing in abundance in the 











Figure 4.6 Dynamic metabolic network participating in metabolite-induced cell fate 
modification of dorsal and ventral cells. Key: left-star (★) denotes isotope pattern 
derived from injection of methionine into D11 cell to induce dorsal-to-ventral tissue 
fate. Right-star (★) corresponds to isotope pattern resulting from injection of 
threonine into V11 to induce ventral-to-dorsal cell fate. Double-dagger (‡) indicates 
significant changes in abundance calculated by ANOVA. Metabolites in grey were 
not detected. 
 
A similar trend was observed after injecting threonine into the V11 cell to 
induce ventral-to-dorsal tissue fate. For example, threonine-injected ventral clones 
revealed heavy isotope incorporation of serine, choline, aspartate and thiamine. Other 
metabolites such as arginine, putrescine, and glutathione showed incorporation of 
heavy isotopes from the methionine isotope tracer, as well as additional changes in 
concentrations identified by ANOVA (Table 4.1). As previously mentioned, ventral 
clones injected with threonine showed an enrichment in the glutathione metabolism, 
suggesting the rapid initiation of the glutathione pathway as a response to oxidative 
stress caused by metabolite concentration alteration. Although we identified similar 






metabolic responses of these cell types to metabolite injections that alter cell fate are 
distinctive (see Fig. 4.6). It appears that some metabolites partake in fundamental 
mechanisms in the cell, for example, aspartate and glutamine play essential roles as 
energy source for the embryo and were found to be equally important to cell fate 
commitment. Likewise, we observed isotopic incorporation and metabolite abundance 
changes that are unique to the dorsal or ventral cell type, emphasizing the importance 
of single-cell measurements to uncover molecular processes that lead to neural and 
epidermal tissue fates. 
4.4 Conclusions 
 In the presented work, we uncovered dynamic metabolic pathways that 
participate in cell specification of dorsal and ventral clones during early stages of X. 
laevis embryonic development. First, we determined metabolites that can alter dorsal 
and ventral cell fate commitment and designed a stable isotope labeling strategy 
compatible with the live embryo to elucidate dynamic metabolism. By implementing 
stable isotope labeling and single-cell MS, we investigated metabolism of normal 
(control) and metabolite-injected dorsal and ventral clones and uncovered previously 
unknown changes in metabolic activity. Our data suggest that the glutathione 
metabolism plays an important role in early developing embryonic cells, as they 
establish their corresponding tissue fates. The metabolic trends identified in this work 
corroborate previous findings at the whole-embryo level and open new frontiers to 
study metabolism of individual cells. We also discovered the rapid remodeling of the 






metabolites (e.g., aspartate and glutathione) that appear to contribute to the 
reestablishment of cell specification. Finally, we verified the effect of isotope tracer 















Chapter 5: Cell-by-cell interrogation of metabolic activity 
uncovers small-molecule gradients in the live frog embryo 
 
 
Based on material in preparation for submission by Erika P. Portero, Leena Pade, Jie 
Li, and Peter Nemes*.  
5.1 Introduction 
 Detection and quantification of biomolecules in single cells is essential to 
enhance our understanding of biochemical processes that take place to establish cell 
functionality and heterogeneity.71, 88 Although recent developments in single-cell 
mass spectrometry (MS) have enabled the characterization of metabolic differences 
among neurons,14 trichome93 and Allium cepa cells,94 sampling the fast-changing 
metabolome during live development still presents a major analytical challenge. Due 
to the volume-limited sample afforded by single cells and the complexity of the 
metabolome, fast and minimally invasive sampling techniques are required. 
Currently, a variety of analytical tools coupled to MS have been devised to study the 
metabolome of single cells including single probe,28, 167 microprobe,55 
microsampling,29 patch clamp pipette,56 live single-cell video MS,168 and 
microdissection of cells.12, 57 In Chapter 2, I discussed the development of 
microprobe55, 101 as a sampling technique for single-cell metabolomics. Microprobe 
sampling was designed to assist in the collection, handling, and extraction of small 
sample volumes from cells of the 8-, 16-, and 32-cell X. laevis embryo.55 In this 
chapter, I apply microprobe CE-ESI-MS analysis to investigate spatial metabolic 






 Spatial and temporal mapping of biomolecules during embryonic development 
can provide new insights into mechanisms that underlie tissue differentiation and 
organogenesis. For instance, recent studies have focused on understanding the role of 
metabolites in cell division and differentiation144, 165 and their implications in 
developmental biology.13, 169 Since metabolites are effector molecules that act 
downstream to transcriptional and translational changes, a metabolic analysis can 
help uncover the physiological state of the cell.64 Previous studies conducted  in the 
Nemes lab characterized metabolites in embryonic cells of the Xenopus laevis frog 
and investigated changes in cell fates caused by metabolite injections.12 Additional 
studies have uncovered the significance of small molecules and gap junctional 
communication in early development and morphogenesis.170 Gap junctions act as 
channels for the passage of metabolites between adjacent cells, supporting cell-to-cell 
communication and serving as important mediators for small molecule signaling 
within embryonic cells.171-173 Specifically, gap junctions were found to play a role in 
establishing left–right symmetry in early developing X. laevis embryos. Thus, it was 
demonstrated that modulating junctional communication leads to heterotaxia in 
developing embryos.170 
In this work, microprobe CE-ESI-MS was utilized to characterize metabolites 
among four adjacent cells located in the left–animal axis of the 16-cell X. laevis 
embryo. Using cluster analysis, we uncovered metabolite concentration gradients 
across selected dorso-ventral cells. Besides empowering statistical analysis by 
minimizing embryo-to-embryo metabolic variability, microprobe CE-ESI-MS 






isotopically labeled metabolites and single-cell MS analysis. The results demonstrated 
the effective transfer of small molecules (e.g., methionine, threonine) between dorsal 
and ventral cells. Furthermore, using fluorescent cell lineage tracing, we investigated 
the effect of metabolite injections to cell fate alteration between adjacent dorsal cells. 
Finally, a color preference behavioral assay was conducted to test the visual function 
of X. laevis tadpoles (stage 45) injected with a metabolite that alters the tissue fate of 
neural-fated dorsal cells.  
5.2 Experimental 
5.2.1 Chemicals and solutions 
LC-MS formic acid, methanol, acetonitrile, and water, as well as phosphate 
buffered saline (PBS, 100X) solution, melatonin, and Alexa Fluor Dextran 488 (FD) 
were purchased from Fisher Scientific (Fair Lawn, NJ). Acetylcholine chloride, L-
methionine were from Acros Organics (Fair Lawn, NJ). Carbenoxolone disodium 
salt, ficoll PM 400, 13C4,15N-L-threonine, and 13C5,15N-L-methionine were purchased 
from Sigma–Aldrich (Saint Louis, MO). Cysteine, diethyl pyrocarbonate (DEPC), 
and paraformaldehyde were from MP Biomedicals (Solon, OH). 
Steinberg’s solution (SS), 2% cysteine, 4% paraformaldehyde in PBS, 0.1X 
Marc's Modified Ringer's (MMR) solution, and 3% ficoll were prepared following 
previous protocols.126 The “extraction solution” contained 40% (v/v) acetonitrile and 
40% (v/v) methanol in MS-grade water at pH 4.70.57 The CE “background 






CE-ESI “sheath liquid” contained 50% (v/v) methanol and 0.1% (v/v) formic acid in 
MS-grade water. 
5.2.2 Microprobe fabrication 
 Borosilicate glass capillaries (part no. B100-50-10, 0.5/1 mm inner/outer 
diameter, Sutter Instruments, Novato, CA) were first pulled to narrow tips with ~900 
µm barrel length using a micropipette puller (model P-97, Sutter Instruments, Novato, 
CA) following earlier protocols.55, 101 The aperture of each micropipette tip was ~20 
µm inner diameter. 
5.2.3 Animals and embryo collection  
 Male and female Xenopus laevis frogs were obtained from Nasco (Fort 
Atkinson, WI) and maintained in a breeding colony at the University of Maryland, 
College Park. All protocols related to the maintenance and handling of Xenopus 
laevis were approved by the Institutional Animal Care and Use Committee (IACUC 
no. R-DEC-17-57). Fertilized embryos were obtained via gonadotropin-induced 
natural mating of adult frogs and the jelly coats from freshly-laid embryos were 
removed using a 2% cysteine solution following established protocols.126 Dejellied 
embryos were kept in Petri dishes containing 100% SS, and 2-cell embryos showing 
stereotypical pigmentation patterns134 across the left-right axis were transferred into a 
separate Petri dish. Embryos were cultured at 14 ˚C until they reached the 16-cell 
stage and transferred to a dish containing 3% ficoll in 100% SS. In each embryo, the 
midline-left ventral V11, V12, and dorsal D11 and D12 cells were identified based on 






5.2.3 Single-cell microprobe sampling  
 A fabricated microprobe was mounted on a micromanipulator (Harvard 
Instruments, Holliston, MA) and the tip was fine positioned into the target cell under 
a stereomicroscope. A ~10 nL portion of the cell’s content was aspirated using a 
microinjector operated in the fill mode (model PLI-100A, Warner Instruments, 
Hamden, CT). Thereafter, the microprobe tip was retracted from the cell, and the 
microinjector was reversed to the injection mode to eject the captured cytoplasmic 
fraction into a micro vial containing 4 µL of extraction solvent chilled to ~4 °C. The 
cellular content of each target cell was microaspirated using separate microcapillaries 
to avoid potential contamination among samples. Metabolite extracts were vortex-
mixed for 1 min at room temperature and centrifuged at 8 000 ×g at 4 ˚C for 5 min. 
Vials containing metabolite extracts were stored at –80 ˚C until measurement by CE-
ESI-MS. For each cell type, n = 3 ̶ 5 biological replicates were sampled (same cell 
type measured from different embryos). Additionally, each cell extract was measured 
in 2–3 technical replicates. This study was comprised of embryos from 1 and 2 sets of 
parents to compare and minimize genetic variability. 
5.2.4 Regulating metabolite transfer  
 Fertilized 2-cell embryos were selected based on stereotypical pigmentation 
patterns and isolated in a Petri dish containing 100% SS. Control embryos were 
monitored under a stereomicroscope until they reach the 8-cell stage and injected into 
the D1 cell with a 2 nL solution containing 20 mM 13C4,15N-L-threonine and 10 mM 






carbenoxolone into the DL cell at the 4-cell stage to inhibit transjunctional 
communication between cells. Then, injected with 20 mM 13C4,15N-L-threonine and 
10 mM 13C5,15N-L-methionine into the D1 cell. Additionally, a set of 2-cell embryos 
was cultured in 860 µM melatonin in 0.1X MMR solution to promote transjunctional 
transfer and injected with isotopically labeled methionine and threonine at the 8-cell 
stage. 
Injected embryos were kept in 100% SS and monitored under a 
stereomicroscope until the 16-cell stage. Individual fabricated microcapillaries were 
used to aspirate cellular content from identified left D12 and V12 cells from the same 
embryo, as previously described. Each cell specimen was expelled into micro vials 
containing 4 µL extraction solution chilled to ~4 °C. Metabolite extracts were vortex-
mixed and centrifuged as noted above and kept in –80 °C until CE-ESI-MS analysis. 
5.2.5 Metabolite injections and dual-fluorescent cell fate tracking  
 Individual 2-cell embryos were transferred into a Petri dish containing 100% 
SS and cultured at 14 ˚C until they reached the 16-cell stage. Then, embryos were 
transferred into a dish containing 3% ficoll and 100% SS solution and the midline 
dorsal-animal D11 and D12 cells were identified following established cell fate 
maps.58-59 In control embryos, a 2 nL volume of a mixture containing 100 pg/nL 
green-fluorescent protein (GFP) mRNA was injected into the D11, while 2 nL of 100 
pg/nL red-fluorescent protein (RFP) mRNA was injected into the D12. The first 
experimental group was injected with 2 nL 75 mM methionine in GFP mRNA into 






was injected with 2nL GFP mRNA into the D11 cell, and 75 mM methionine in RFP 
mRNA into the D12 cell. Each control and experimental group consisted of ~50 
injected embryos. Approximately 20 min after the injection, embryos were transferred 
into Petri dishes containing 50% SS and monitored until they reached the larval stage. 
At stage 34, the larvae were fixed using 4% paraformaldehyde and 3% sucrose in 
phosphate-buffered saline (PBS) solution for 1 h. Finally, the fixed larvae were rinsed 
with 1× PBS solution and stored at 4 °C. 
5.2.6 Phenotyping  
Larval stage embryos (stage 34) were imaged using a confocal microscope 
(Leica SP5X, Buffalo Grove, IL). To conduct lineage analysis, embryos were 
examined and imaged using epifluorescence on a research-grade stereomicroscope 
(model SMZ18 equipped with SMZ-25/18 P2-EFLC EGFP BP HC Filter Set, Nikon, 
Melville, NY). The relative contribution of fluorescence to the organ/tissue fate was 
scored following original guidelines used to determine cell fate maps.58 The scoring 
was assigned as follows, a “0” indicated no labeled cells in the tissues of interest; “1” 
indicated ≤ 10 labeled cells; “5” indicated at least 50% labeled cells; and “10” 
indicated that the tissue was entirely covered by labeled cells. To compare differences 
between control and experimental dual-fluorescent labeled cells, two-tailed Mann-
Whitney U test and student’s t-test were calculated in OriginPro 2016 (OriginLab, 







5.2.7 Metabolite detection  
 Metabolite extracts were centrifuged at 8 000 ×g at 4 °C for 5 min to pellet 
cell debris and precipitated proteins before analysis in a laboratory-built CE-ESI-MS 
platform as previously described.12, 55, 100 Briefly, the laboratory-built CE stage 
comprised of a 1-meter fused silica capillary (40/102 µm inner/outer diameter) with 
the capillary inlet submerged in background electrolyte (BGE) containing 1% (v/v) 
formic acid, and the outlet connected to a co-axial sheath-flow interface that supplied 
sheath liquid at 0.6 µL/min. Electrophoretic separation of small molecules was 
conducted by applying 18–20 kV. Generated ions were analyzed using a quadrupole 
orthogonal-acceleration time-of-flight mass spectrometer (Impact HD, Bruker 
Daltonics, Billerica, MA) with the following settings: –1,700V spray voltage (applied 
to the front plate orifice); MS survey scan rate, 2 Hz; mass range (MS1 and MS2), 
m/z 50–550; collision-induced dissociation (using nitrogen gas) energy, 18–20 eV; 
dry gas, 100 °C with a flow rate 2 L/min. 
5.2.8 Data analysis 
 Raw mass spectrometric data files were processed in Compass Data Analysis 
version 4.3 (Bruker Daltonics) using a custom-written data analysis script.12 Each 
data file was externally mass-calibrated (enhanced quadratic calibration in Compass) 
for sodium-formate cluster ions that formed in the ESI source. Molecular features 
(unique m/z vs. migration time domains) were semi-automatically searched between 
m/z 50–550 with a 5 mDa window and their accurate mass and selected-ion peak area 






4.0120 with the following settings: normalization by sum; log transformation; data 
auto scaling. Unsupervised principal component analysis (PCA), statistical tools (e.g., 
T-test, ANOVA, etc.) and hierarchical cluster analysis (HCA) were performed on 
MetaboAnalyst using statistically significant features (p<0.05) and Euclidean distance 
measure. Cluster analysis was performed in GProX ver.1.1.16174 with the following 
settings: cluster number, 0-4; upper limit, 1.5; lower limit, 0.75; fuzzification value, 
2; minimum membership for plot, 0.5; standardizations and 100 iterations. 
5.2.9 Color preference behavioral assay 
 To test the visual function of Xenopus laevis tadpoles (stage 45) after 
methionine injection into dorsal D11 and D12 cells, a color preference behavioral 
assay was conducted following a previously established protocol.175 All protocols 
related to the maintenance and handling of Xenopus laevis tadpoles were approved by 
the University of Maryland Institutional Animal Care and Use Committee (IACUC 
no. R-JUN-20-31). Two cell embryos were collected in a Petri dish containing 100% 
SS and cultured at 14 ˚C until they reached the 16-cell stage. The control group (n = 
15) consisted of wild-type 16-cell embryos cultured in 50% and 20% SS at room 
temperature (20–21 °C) to stage 45. Experimental groups consisted of metabolite-
injected clones of corresponding D11 and D12. A volume of 2 nL of L-methionine 
was injected into D11 (n =10) or D12 (n =15) cells in separate embryos at the 
following concentrations: 75 mM (1×) and 150 mM (2×). Injected embryos were 
transferred to 50% SS and cultured at room temperature until they reached tadpole 






 The “test tank” consisted of two-tanks: an outer tank with one half covered 
with black electrical tape and the second half covered with white paper, and an inner 
tank filled with 20% SS at ~5 cm height. Next, a camera (Canon EOS 70D, Canon 
USA, Huntington, NY) was placed on a tripod and adjusted to visualize the testing 
area. A lightweight white cloth was placed over the setup to reduce external lighting 
and maintain luminance between 40–50 cd/m2. 
 Using a large-aperture pipette, an individual tadpole was carefully transferred 
to the white-side of the “test tank”. Immediately, the first trial was recorded using the 
camera setup for 2 min. Then, the inner tank was rapidly elevated while the outer tank 
was rotated 180° and placed back into the outer tank. A second trial was recorded for 
2 min, then the tadpole was returned to a dish containing 20% SS. Control and 
experimental groups were tested on 2 consecutive days. After the trials were finished, 
the recordings were manually analyzed by noting down the amount of time individual 
tadpoles spent on the white side of the tank. The position of the tadpole was 
determined based on the location of the eyes. A tadpole was considered to cross the 
black/white line only when both eyes were found on either black or white locations. 
The data was analyzed using two-tailed Mann-Whitney U test calculated in OriginPro 






5.3 Results and discussion 
5.3.1 Microprobe sampling of cells in the same embryo uncovered metabolite 
gradients 
 The goal of this work was to characterize metabolites among cells in the same 
vertebrate embryo. We recently adapted and validated microprobe microsampling to 
conduct in situ and temporal analysis of the metabolome in dorsal embryonic cells 
from 8  ̶32 cell stages of the Xenopus laevis embryo.55, 101 Although only a small 
portion of the cell was extracted, it was demonstrated that microprobe sampling is 
able to detect a comparable number molecular features (unique m/z and migration 
time) compared to a microdissection workflow.12 Additionally, microprobe sampling 
minimized oxidative stress and physical damage caused to neighboring cells while 
collecting inner cellular content. In this study, I targeted four adjacent cells in the 16-
cell South African Xenopus laevis frog embryo (Fig. 5.1), a well-established model in 
cell and developmental biology. Animal dorsal-ventral cells located on the left side of 
the embryo were exclusively sampled since a previous study conducted by the Nemes 
lab uncovered left-right metabolic asymmetry in the 8-cell embryo.57 Moreover, these 
cells were strategically chosen because they are fated to develop into distinct tissues 
and organs as determined by corresponding cell fate maps.58 For example, the D11 
cell gives rise to part of the central nervous system, including the brain and retina, 
while the D12 cell reproducibly gives rise to the spinal cord, otocyst and head 
epidermis. On the other hand, the V12 cell forms part of the neural crest, and the V11 






utilized fabricated borosilicate micropipettes (µP) with a needle-tip outer diameter of 
~20 µm to extract a small portion of cellular content 10–15 nL from individual cells. 
Importantly, after microsampling individual cells of the 16-cell embryo, there was 
minimal damage observed among the cells. Next, the extracted portion of the cell was 
immediately transferred to a microvial containing 4 µL of metabolite extraction 
solvent as described in the experimental section. Metabolite extracts form each cell 
were measured using our customized single-cell CE-ESI-MS platform12, 100-101 and the 
resulting metadata was analyzed to interpret metabolite heterogeneity among dorso-
ventral cell types. 
 
Figure 5.1 Analytical pipeline enabling the metabolic differentiation of dorsal and 
ventral single cells in a live embryo. A ~10 nL portion of cytoplasm from D11 (neural 
fate), D12 (head epidermis fate), V12 (cranial ganglia and epidermis fate), and V11 
(head and truck epidermis fate) X. laevis embryonic cells were aspirated using a 
microprobe (µP). Samples were analyzed by CE-ESI-MS. Scale = 250 µm. 
 
Using CE-ESI-MS, we detected about ~140 distinct molecular features in 
single-cell extracts, from which 90 were identified as metabolites (Appendix 5.1). 






metabolite identification was conducted by comparison of accurate masses to a 
database (e.g., METLIN43 and HMDB3), comparison of migration time (MT) to one 
of a known metabolite standard, and comparison of tandem-MS patterns to chemical 
standards or available spectra in online databases. To compare the relative abundance 
of detected molecular features among dorso-ventral cell types, we used under-the-
curve peak area as a proxy to metabolite concentration. 
Next, we conducted unsupervised principal component analysis (PCA) based 
on ~140 molecular features from n = 3 embryos of same parental origins (Fig. 5.2A), 
which revealed no discrete clustering of the D11, D12, V12 and V11 cell types based 
on the their corresponding metabolite profiles. This result was in agreement with 
previous findings that suggest the existence of embryo-to-embryo metabolic 
heterogeneity during the cleavage stages of embryonic development.13 Surprisingly, 
when comparing technical triplicates measured by CE-ESI-MS using PCA, a distinct 
clustering based on cell types was observed (Fig. 5.2C), which indicates that cell type 
differences at the level of metabolites could be masked by embryo–embryo 
differences. Consequently, we performed unsupervised hierarchical clustering 
analysis (HCA) (Fig. 5.2B) of the 75 most statistically significant molecular features 
determined by analysis of variance ANOVA. Interestingly, HCA showed differential 
clustering based on cell types (top axis) and relative metabolite abundance (left axis). 
For example, in the case of the arginine-alanine (Arg-Ala) and serine-alanine (Ser-
Ala), their corresponding concentration pattern indicates higher concentration of both 
in V11 (highest) and D12 cells , while a lower in D11 and V12 (lowest) was 






histidine, choline) with similar concentration trends where the highest concentration 
is found in D12 and V12 cells, and the smallest concentration is found in D11 and 
V11 cells. This result indicates that microprobe CE-MS is amenable to uncover 




Figure 5.2 Overall differences between embryos can mask cell-to-cell differences in 
the metabolome. (A) PCA shows overlap between cell types (V11, V12, D11, and 
D12) when comparing multiple embryos. (B) Hierarchical clustering ̶ heatmap shows 
the technical reproducibility achieved per measurement of each cell type. (C) Cell 
types can be differentiated via PCA when looking at the metabolite distribution of an 
individual embryo. Key: AcCar, Acetylcarnitine; AcCho, Acetylcholine; Car, 










5.3.2 Dorso-ventral metabolite transport and modulating GJC 
An unsupervised data clustering and visualization tool such as GProx,174 (Fig. 
5.3A) was used to generate and interpret metabolite concentration patterns across left 
dorso-ventral cells. A total of 84 molecular features were grouped into 4 different 
clusters based on their corresponding spatial abundance from the D11 cell towards the 
V11 cell. A complete list of molecular features and assigned cluster groups is 
presented in Appendix 5.2. Molecular features allocated to cluster 0 represent 
molecules found at a steady concentration across all cells. Interestingly, clusters 1 and 
2 follow similar concentration patterns, as the highest metabolite concentration was 
found in the D11 cell and progressively decreasing in abundance towards the D12, 
V12, and V11 cells. However, in cluster 1 the lowest concentration is located at the 
V12 cell whereas cluster 2 shows a low concentration at the V11 cell. Cluster 3 
presents a reversed pattern as compared to cluster 1, with the lowest molecular 
abundance found in the D11 cell and the highest at the V12 cell. Finally, cluster 4 
depicts a unique pattern where both the D11 and V11 cells contain the highest level 
of metabolites. At first glance, the concentration gradients observed across dorso-
ventral cells could result from various developmental processes taking place during X. 
laevis embryogenesis. Due to the similarities in metabolite concentration trends 
between clusters 1 and 2, we hypothesized that these gradients could be a product of 
intercellular communication via gap junction channels that regulate metabolite 
transport between cells.176 Recent measurements in 16- to 64-cell X. laevis 
embryos170, 177-178 revealed that dorsal blastomeres have greater gap junctional 






distribution captured by microprobe CE-ESI-MS reflects on dorso-ventral metabolite 
transfer in the embryo.  
 
Figure 5.3 Metabolite gradients and transport across dorso-ventral cells. (A) 
Unsupervised cluster analysis of small-molecular features in adjacent cells of the 16-
cell X. laevis embryo. (B) Determining transport of metabolites mediated by gap 
junctions using stable-isotopically labeled methionine and threonine. (C) Modulating 
junctional transfer between by introducing inhibitor and promoter molecules. Key: 
ns- not significant. 
 
 To test our hypothesis that GJC may be at play to create metabolite gradients 
in the 16-cell embryo, we developed a strategy where stable isotope metabolites are 
injected into target cells followed by single-cell CE-ESI-MS analysis. For example, 
isotopically labeled threonine (cluster 1) and methionine (cluster 2) were co-injected 
as a mixture into the D11 cell, then the embryo was cultured for 10–15 min and 






cell CE-ESI-MS analysis. Next, the isotopically labeled metabolite mixture was 
injected into the D12 cell in a separate group of embryos and later sampled at the D12 
and V12. Finally, we injected the metabolite mixture into the V12 cell to investigate 
the small molecule transfer between V12 and V11 cells, as seen in Figure 5.3B. A 
ratio (Equation 5.1.) was used to calculate whether isotopically labeled threonine or 
methionine had migrated between neighboring cells, as follows: 
                   Ratio =
  ( ∗  ∗)  
∑   ( ∗  ∗)  
           (Equation 5.1) 
For instance, if the isotopically labeled metabolites were injected into the D11 cell 
and both D11 and D12 cells were sampled and analyzed; then a ratio of 1 following 
Equation 5.1 would indicate no metabolite transport to the adjacent cell, while 0 
would indicate total transfer of the metabolite. Remarkably, we found that methionine 
transport is favored between dorsal, dorso-ventral, and ventral cells (Fig. 5.3B). On 
the other hand, threonine followed a similar pattern where metabolite transport was 
detected between dorsal and ventral cells, but no transfer was detected between 
dorso-ventral D12 and V12 cells. This observation is consistent with the metabolic 
concentration profile displayed by cluster 1 (Fig. 5.3A). Additionally, we investigated 
metabolite transfer from V11 cell in the direction towards the D11 cell (Fig. 5.3B, 
bottom). Interestingly, it was found that threonine does not migrate in a ventral-to-
dorsal directionality. Our observations of small-molecule transfer between dorsal 
cells in the 16-cell embryo are in agreement with previous studies that characterized 






 To further characterize the extent of small molecule transfer via GJC, we 
treated embryos with drugs known to inhibit junctional conductance such as 
carbenoxolone,180 and melatonin170, 181 which facilitates GJC (Fig. 5.3C). Embryos in 
the 4-cell stage were injected with carbenoxolone into the DL cell, then co-injected 
with isotopically labeled methionine and threonine into the D1 cell, and finally 
microprobed into D12 and V12 cell in the 16-cell embryo. Our results show that the 
addition of carbenoxolone significantly reduces the transfer of methionine towards 
the V12 cell. There was no change in the transfer pattern previously observed with 
threonine. A second set of embryos were cultured in a solution containing melatonin 
at the 2-cell stage, co-injected with isotopically labeled metabolites, and microprobed 
into the D12 and V12 cells. Adding melatonin into the culturing media significantly 
increased the transfer of threonine into the V12 cell. Overall, our collective results 
suggest that metabolite gradients observed in the 16-cell X. laevis embryo could 
indeed result from GJC. Moreover, previous studies demonstrated that gap junctional 
communication variations effectively take place during early embryogenesis; thus, 
junctional permeability plays an important role in establishing the orientation of body 
axes.170, 179 
5.3.3 Tracking cell fate changes in adjacent neural-precursor cells 
 In the last decade, several studies have focused on understanding the 
mechanisms that allow the vertebrate embryo to reliably self-assemble via body 
patterning.172 Given the complexity of the underlying events that take place during 






role to enable information flow between cells and tissues. Therefore, direct cell-to-
cell exchange of small molecules through gap junctions is essential to establish 
communication between neighboring cells.182 This notion is supported by the findings 
in this study, where we discovered the effective transfer of methionine between 
dorso-ventral cells in the 16-cell X. laevis embryo. In Chapter 4, I investigated cell 
fate changes caused by injection of methionine and acetylcholine into the dorsal D11 
cell. Since our earlier work demonstrated that injecting methionine into the neural-
fated D11 cell causes a decrease in fluorescent lineage of cells that form the brain, 
lens, and olfactory placode; we hypothesized that the cell fate of the neighboring D12 
cell may also be affected due to junctional transfer of methionine.  
To test our hypothesis, we performed dual-fluorescent labeling of D11 and 
D12 cells in the same embryo by injecting two fluorescent-protein mRNA lineage 
tracers. A control group consisted of 16-cell embryos injected with green-fluorescent 
protein (GFP) into the D11, and red-fluorescent protein (RFP) into the D12 to trace 
cell fates in the larval stage 34 (Fig. 5.4). In the first experimental group, a mixture of 
methionine and GFP was injected into the D11 cell to induce an epidermal cell fate, 
while D12 was injected with RFP. Finally, a mixture of RFP and methionine was 
injected into the D12 cell, while the D11 cell was fluorescently traced with GFP. 
Bright-field and fluorescent microscopy was used to score the relative cell 
contribution to brain, retina, lens, spinal cord, olfactory placode, cement gland, 
otocyst, branchial arches, and epidermis following established protocols.58 We 






(p-value <0.05) between control and experimental groups. Table 5.1 summarizes 
statistical p-values obtained after performing student’s t-test using tissue scores. 
  
Figure 5.4 Dual-fluorescent labeling of dorsal cell clones in X. laevis larva (stage 34). 
Methionine injection into the D11 and D12 cells revealed cell fate changes to 
corresponding neighboring cells. Scale bar = 200 µm. 
 
Our results demonstrate that injection of methionine into the D11 and D12 cell 
can induce cell fate changes on the immediate dorsal-adjacent cell (Fig. 5.4). For 
example, upon injection of methionine into the D11 cell, fluorescently derived cells 
of the D12 (red, RFP) contributing to the retina, lens, and olfactory placode 
significantly decrease. Similarly, injection of methionine into the D12 cell shows a 
notable effect in the formation of brain, lens, spinal cord, and olfactory placode 
derived from D11 cell clones (green, GRP). Thus, the data provided herein validate 
our notion that altering methionine concentration in dorsal cells coupled with 
junctional communication in the early X. laevis embryo can ultimately intervene with 







Table 5.1 Student’s t-test and p-values of tissue scores after metabolite injection into 
D11 or D12 cells in 16-cell X. laevis embryos.  
Student’s t-test Methionine into D11 Methionine into D12 
Tissue D11  D12  D11  D12  
Retina 0.152 4.9E-04 0.939 0.256 
Lens 0.003 0.001 0.041 0.088 
Brain 0.013 0.053 0.048 0.609 
Spinal cord 0.223 0.602 4.3E-04 0.004 
Olfactory placode 0.055 3.3E-06 0.018 0.091 
Cement gland 0.059 0.208 0.260 0.175 
Otocyst 0.098 0.817 0.074 0.065 
Branchial arches 0.719 0.655 0.057 0.403 
Head epidermis 0.002 0.510 0.861 0.014 
Body epidermis 5.9E-05 0.550 0.186 0.017 
 
5.3.4 Behavioral assay on metabolite-injected tadpoles reveals visual deficit 
Last, we measured the visual function of X. laevis tadpoles injected with 
methionine at the 16-cell stage using an recently established color preference 
behavioral assay for Xenopus laevis tadpoles.175 Since D11 and D12 cells give rise to 
neural structures such as the retina, lens, and brain; we tested whether methionine 
injection into individual cells at 1× and 2× concentrations (see experimental section) 
impairs visual function at tadpole stage 45. Control or wild-type tadpoles were 
selected at the 2-cell stage and cultured at room temperature until the tadpole stage. 
Experimental groups were injected into D11 and D12 cells with methionine in 1× and 
2× concentrations, correspondingly. Then, tadpoles were placed in a test tank 
consisting of a half-tank covered in white, while the second half is covered in black 
(Fig. 5.5A). In previous studies, it was noted that when placing a tadpole in a half-






the white side of the tank.183 Based on this notion, we expected that tadpoles with 
intact visual function would prefer to swim towards the white side of the test tank.  
 
 
Figure 5.5 Color preference behavioral assay performed to test visual function of X. 
laevis tadpoles (stage 45). (A) Test tank consisting of half-white and half-black 
background color. (B) Methionine was injected into the D11 cell in 1× and 2× doses. 
Statistical analysis reveals a deficit in visual function in tadpoles receiving a 2× 
metabolite injection. (C) Injection of 1× and 2× doses of methionine into D12 cell 










Our preliminary results (Fig. 5.5B) indicate that a 1× injection of methionine 
into the D11 cell (n = 10) does not seem to affect visual function in X. laevis tadpoles, 
since the percentage of time spent on the white side of the tank is comparable to the 
control (untreated) group (n = 15). However, a 2× dose of methionine (n = 10) shows 
a significant decrease in the amount of time tadpoles spent on the white side of the 
tank. On the other hand, 1× (n = 15) and 2× (n = 15) methionine injections into the 
D12 cell (Fig. 5.5C) show a significant deficit in visual function of injected tadpoles 
due to the reduction of time spent on the white side of the tank. To avoid a 
directionality bias (e.g., by placing the tadpole on one side of the tank only), we 
tested each tadpole by placing it on the right side of the tank and sequentially rotating 
the tank to expose the tadpole to the opposite side (Fig. 5.5A). Additionally, tadpoles 
were tested during two consecutive days to ensure the reproducibility of our 
measurements. Interestingly, the results obtained with the color-preference behavioral 
assay described in this work suggest that visual function of X. laevis tadpoles could 
be impaired upon injection of methionine into neural-fated dorsal cells of the 16-cell 
embryo.  
5.4 Conclusions 
In this work, we demonstrated that microprobe can be effectively used to 
enable the analysis of multiple cells in the same embryo. We also uncovered embryo-
to-embryo metabolic heterogeneity and have minimized statistical and biological 
variability that could hinder the analysis of cell heterogeneity in the developing frog 






dorso-ventral cells in the 16-cell embryo resulting from possible metabolite exchange 
through gap junctional communication (GJC). Remarkably, we found that methionine 
transport between neural-fated dorsal cells can alter their corresponding tissue fates, 
further validating the importance of GJC for early embryonic development and 
organogenesis. Finally, the preliminary results obtained from a color-preference 
behavioral assay indicate that perturbing methionine abundance in dorsal cells can 









Chapter 6:  Conclusions and future directions  
 
6.1 Advancing single-cell metabolomics and developmental biology  
 Single-cell metabolomics by MS provides a powerful tool to study molecular 
mechanisms responsible for cell heterogeneity. Classical MS-based analytical 
workflows are designed to characterize biomolecules in bulk cell populations (e.g., 
tissues, blood, etc.) but it has been observed that cell populations are not necessarily 
homogeneous.64, 184-185 Therefore, to understand the chemical diversity between cell 
types and subtypes, it is important to conduct molecular profiling at the single cell 
level. To this end, several analytical approaches have been refined to enable single-
cell metabolomics. However, due to the large chemical diversity, fast turnover rates 
of the metabolome, and limited sample volume afforded by single cells, there is still a 
need to improve current technologies. 
 The work presented herein accomplished several technological advances 
towards the analysis of metabolites in single cells of the vertebrate X. laevis embryo. 
First, we adapted microprobe sampling to enable minimally intrusive sample 
collection of ~10–15 nL content from X. laevis embryonic single cells55 (Chapter 2). 
This microprobe sampling methodology was compatible with the morphologically 
complex structure of the vertebrate embryo. Additionally, based on the effectiveness 
demonstrated by microprobe to collect sample from the live embryo, we utilized this 
approach to interrogate temporal (Chapter 4) and spatial cell heterogeneity (Chapter 
5). Next, we advanced a laboratory-built CE-ESI-MS platform to facilitate the dual 






expand the detectable coverage of the single-cell metabolome. The CE-ESI-MS 
platform offers high sensitivity, ~5–10 nL (50–100 amol) lower limit of detection, 
and quantification capabilities to detect endogenous metabolites and 
neurotransmitters in single cells.  
 In this work, we demonstrated that combining cell identification using cell 
fate maps58-59 with ultra-sensitive CE-ESI-MS, empowers the study of metabolism 
during early embryonic development. Our results revealed surprising spatial and 
temporal metabolic cell heterogeneity in the embryo. For instance, we conducted cell 
lineage studies to determine metabolites and their corresponding concentrations 
needed to induce cell fate changes (Chapter 4). Then, by profiling metabolites from 
neural-fated cells of the 16-, 32-cell, stage 8, and 9 embryos, we discovered the 
reorganization of the metabolome upon injection of select metabolites that induce 
neural- to epidermal-cell fates. While the active molecular mechanisms that drive 
metabolite-induce cell fate determination remain elusive to us at this point, our 
established CE-ESI-MS analytical platform and findings can allow us and others to 
conceive new hypotheses and research strategies to understand how metabolite 
heterogeneity contributes to cell specification in the early developing embryo.  
Moreover, we uncovered spatial metabolic heterogeneity in the same embryo 
(Chapter 5) and investigated transjunctional transport of metabolites between adjacent 
cells. Our findings support previous studies that characterized the importance of gap 
junctional communication for the establishments of body-axes during 
embryogenesis.170, 177 Our data provides new information to understand the role of 






research possibilities for cell and molecular biology. To validate the significance of 
cell-to-cell communication and metabolite transport for body patterning and 
organogenesis, future studies should focus on the development of functional assays 
that probe and examine metabolite-induced organ development irregularities (e.g., 
heterotaxia, hypoplasia) during later stages of growth. Results from these and other 
future experiments are expected to delve into the significance of small molecules for 
the normal and impaired development of the vertebrate embryo.  
6.2 Technological advancements needed for single-cell metabolomics  
 Improvements in metabolite detection. To facilitate the analysis of 
metabolites from single cells, I developed a single-cell CE-ESI-MS platform that 
enables dual anionic-cationic metabolite detection from single cell extracts,30 with the 
goal of improving metabolite coverage. This analytical platform was able to detect 
~250 cationic and ~200 anionic molecular features from a single cell, including 60 
and 24 identified metabolites, respectively. Additional technological advances to our 
platform may be implemented to aid with metabolite detection and sensitivity to 
continue improving single-cell metabolite detection. To improve sensitivity, larger 
amounts of samples can be injected into the CE capillary via sample stacking.112 This 
approach is compatible with our platform and likely to yield improved sensitivity for 
metabolite detection and identification. Improvements in CE interface and spray 
stabilization will also result in added detection sensitivity. For example, a decrease in 
sheath-flow from 1 µL to <300 nL/min by incorporating alternative CE-ESI 






nanoESI,108 and even sheathless CE-ESI,186 will result in reduced dilution of analytes 
in the electrospray plume. Combined, these suggested improvements can facilitate 
small molecule detection, which results in a deeper profiling of biomolecules in 
single cells.  
Improvements in throughput. At the moment, a major limitation for the analysis of 
single cells originates from the minuscule amounts of starting material, which can be 
lost during sample preparation. Droplet-based isolation187-188 and microfluidics18, 189 
approaches enable new developments to overcome sample losses and streamline 
single-cell analytical workflows. For example, by combining single-cell printer 
technology with liquid-vortex capture (LVC)-MS,187 a recent study demonstrated 
high-throughput analysis of metabolites in single cells at a rate of ~30 cells/s. Other 
approaches utilized stable isotope labeling assisted microfluidics chip ESI190 to detect 
and quantify metabolites from individual cells. Based on the advantages achieved by 
microfluidic devices, our CE-ESI-MS platform could benefit from further 
advancements and added automatization for sample handling and injection to 
streamline analysis.  
Additionally, to enable the rapid analysis of multiple cells using our CE-ESI 
platform, a multi-segmented sample injection113 into the CE separation capillary can 
significantly boost the analysis throughput of metabolite extracts. Due to the 
difference in migration of charged compounds through the CE capillary, which is 
driven by their distinctive electrophoretic mobility, adequate peak resolution remains 






is that the analysis time can be significantly reduced, thus leading to a fast analysis of 
a larger number of cells.  
Improvements in data analysis. In contrast to chromatographic-based separation 
techniques (e.g., LC), open-access software tools to effectively select peaks (peak-
finding) and correct shifts in migration times are still underrepresented in CE-MS 
based metabolomics. We recently developed Trace,191 which uses machine learning to 
enhance signal detection in CE high-resolution MS analysis and demonstrated high 
accuracy and robustness in data processing throughput for a metabolomics workflow. 
Trace is compatible with open-source MS data format (mzML) and its python code is 
conveniently accessible. Further improvements including the implementation of a 
graphical user interface will facilitate its routine use in CE-MS data analysis 
workflows. Other software tools such as ROMANCE192 have focused on correcting 
migration time shifts by converting migration time into effective electrophoretic 
mobility. The use of electrophoretic mobility raises the potential to aid compound 
identification in biological samples. For example, in a study comprised of 13 
independent laboratories, including our lab, we recently examined migration time 
reproducibility and identification capabilities in CE-MS based metabolomics.193 The 
results revealed that the reproducibility of the electrophoretic mobility for 20 out of 
21 model compounds was below 3.1% vs 10.9% with migration time, regardless of 
the huge heterogeneity in experimental conditions and platforms across the 13 
laboratories. Overall, our findings validate the use of CE-MS as a reproducible 
approach for metabolomics. As such, we expect that future developments of software 







Appendix 4.1 Mann–Whitney U test comparing tissue scores after metabolite injection into D11 or V11 cells in 16-cell X. laevis 
embryos. Key: U, total range; Z, normal distribution test; IQR, interquartile range. 
 Control vs. 
Acetylcholine in D11 Brain Retina Lens Olfactory Placode Cement Gland Branchial Arches C. Somite Epidermis 
U 4180 4090 3644 3846 4055 2920.5 4328 2327 
Z 3.6607 3.3153 1.7814 2.4800 3.2498 0.7269 4.2053 –1.6838 
Exact. Prob. 2.21E–04 7.91E–04 0.0757 0.0131 0.0011 0.4668 1.93E–05 0.0944 
Approx. Prob.  2.52E–04 9.16E–04 0.0749 0.0131 0.0012 0.4673 2.61E–05 0.0922 
Median control  5 5 10 5 1 0 5 1 
Median AcCho  5 1 1 1 0 0 5 5 
IQR control 1–10 1–10 0–10 1–10 0–5 0–1 1–10 0–5 
IQR AcCho 1–5 0–5 0–10 0–10 0–1 0–1 1–5 0–5 
Control vs. Methionine 
in D11 Brain Retina Lens Olfactory Placode Cement Gland Branchial Arches C. Somite Epidermis 
U 3666.5 3175 3372 3732 3780 2272 3199 2452.5 
Z 3.3593 1.4380 2.2757 3.6227 3.8625 –0.8071 1.5439 0.0174 
Exact. Prob. 7.17E–04 0.1534 0.0229 2.60E–04 9.18E–05 0.4249 0.1235 0.9873 
Approx. Prob.  7.81E–04 0.1505 0.0229 2.92E–04 1.22E–04 0.4196 0.1226 0.9861 
Median control  5 5 10 5 1 0 5 1 
Median Met  1 5 1 1 0 0 5 1 
IQR control 1–10 1–10 0–10 1–10 0–5 0–1 1–10 0–5 
IQR Met 1–5 0–10 0–10 0–5 0–1 0–5 1–10 0–10 
Control vs. AcCho + 
Met in D11 Brain Retina Lens Olfactory Placode Cement Gland Branchial Arches C. Somite Epidermis 
U 4585.5 3723.5 4110.5 4070 4346.5 2338 4655 2068 
Z 3.4009 0.5770 1.8740 1.7353 2.6413 –0.5064 3.6358 –1.6385 
Exact. Prob. 6.27E–04 0.5682 0.0610 0.0823 0.0081 0.6116 2.41E–04 0.1029 
Approx. Prob.  6.72E–04 0.5639 0.0609 0.0827 0.0083 0.6126 2.77E–04 0.1013 
Median control  5 5 10 5 1 0 5 1 
Median AcCho+Met  5 5 5 5 1 0 5 3 
IQR control 1–10 1–10 0–10 1–10 0–5 0–1 1–10 0–5 






Control vs. Serine in 
V11 













U 1350 1499 1144 1087 1441 1352 1314 1360 1324.5 
Z 1.0928 2.001 –1.9953 –2.0311 2.1284 1.5168 0.5475 0.7849 0.5089 
Exact. Prob. 0.4149 0.0514 0.1057 0.0439 0.0484 0.1952 0.5974 0.4205 0.6139 
Aprox. Prob. 0.2745 0.0454 0.0460 0.0423 0.0333 0.1293 0.5840 0.4325 0.6108 
Median control  0 0 0 0 0 0 0 5 5 
Median Ser  0 0 0 0 0 0 0 5 5 
IQR control 0–0 0–10 0–0 0–0 0–0 0–0 0–1 1–10 1–5 
IQR Ser 0–0 0–5 0–0 0–0 0–0 0–0 0–0 5–5 1–5 
Control vs. Threonine 
in V11 













U 696 1411 572 799 818 945 803 928 1187 
Z –3.4585 3.1021 –5.1747 –3.1833 –2.3504 –1.5150 –2.3874 –1.2503 0.8944 
Exact. Prob. 5.19E–4 0.0016 3.12E–8 0.0015 0.0189 0.1586 0.0168 0.2138 0.3733 
Aprox. Prob. 5.43E–4 0.0019 2.28E–7 0.0015 0.0188 0.1298 0.0170 0.2112 0.3711 
Median control  0 0 0 0 0 0 0 5 5 
Median Thr  5 0 0 0 0 0 1 5 5 
IQR control 0–0 0–10 0–0 0–0 0–0 0–0 0–1 1–10 1–5 
IQR Thr 0–10 0–0 0–1 0–1 0–5 0–0.5 0–5 5–10 1–5 
Control vs. Ser + 
Thr in V11 













U 1004 1663 946 980 1110 1283.5 1016.5 1282.5 1407 
Z –2.5339 2.7280 –3.8221 –3.2507 –1.6777 –0.3998 –2.2804 –0.2593 0.6111 
Exact. Prob. 0.0115 0.0070 5.64E–5 5.44E–4 0.0930 0.8128 0.0226 0.7987 0.5456 
Aprox. Prob. 0.0113 0.0064 1.32E–4 0.0012 0.0934 0.6893 0.0226 0.7954 0.5411 
Median control  0 0 0 0 0 0 0 5 5 
Median Ser+Thr  0 0 0 0 0 0 0 5 5 
IQR control 0–0 0–10 0–0 0–0 0–0 0–0 0–1 1–10 1–5 


















U 2628 2662 2794.5 2537.5 2911.5 2740 2132.5 2260 2006 
Z 1.1146 1.3046 1.8538 1.0437 2.3417 1.4469 –1.2953 –0.6698 –1.8857 
Exact. Prob. 0.2731 0.1944 0.0666 0.2470 0.0195 0.1490 0.1978 0.5063 0.0615 
Approx. Prob.  0.2650 0.1921 0.0638 0.2966 0.0192 0.1479 0.1952 0.5030 0.0593 
Median control  10 10 10 10 10 1 0 1 0 
Median Thr*  10 10 10 10 5 1 1 1 1 
IQR control 5–10 6.25–10 5–10 10–10 1–10 0–8.75 0–1 1–5 0–1 
IQR Thr* 5–10 0–10 5–10 10–10 0–10 0–5 0–1 1–5 0–1 











U 1025.5 1209.5 1051 1071.5 990.5 1045.5 1054.5 1241.5 1230 
Z –1.1383 1.1721 –0.6662 –0.0703 –1.1129 –0.6300 –0.2163 1.3144 1.3034 
Exact. Prob. 0.3153 0.2504 0.6804 1.0000 0.3257 0.3577 0.8379 0.1927 0.1894 
Approx. Prob.  0.2550 0.2412 0.5053 0.9440 0.2658 0.5287 0.8288 0.1887 0.1924 
Median control  0 0 0 0 0 0 0 5 5 
Median Met*  0 0 0 0 0 0 0 1 5 
IQR control 0–0 0–10 0–0 0–0 0–0 0–0 0–3 1–10 1–5 
















Appendix 4.2 Calculated percent isotope abundance (% [M+1]) for dorsal and ventral clones injected with heavy-isotope tracers.  
      32-cell 
Metabolite  m/z 
Theor. 
% 



























Ornithine  133.0972 6.36 10.31 - 8.01 7.90 8.69 5.77 17.31 - - 8.00 2.45 - 9.63 
Lysine 147.1128 7.50 5.70 10.08 7.01 6.18 6.34 5.70 7.67 6.95 5.54 6.69 6.78 7.01 6.09 
Arginine  175.1190 8.20 9.67 8.43 6.96 6.33 7.21 6.64 4.81 8.83 7.70 6.74 6.58 6.95 5.46 
Acetylcarnitine 204.1230 10.50 6.94 - - 8.55 11.23 9.83 7.17 11.86 10.64 8.83 7.84 7.90 7.42 
Glutamine  147.0764 6.30 8.84 - 5.84 5.19 5.61 4.53 5.94 5.88 5.10 4.93 5.89 5.76 4.91 
Glutamate  148.0604 6.00 3.04 - - 4.14 4.17 4.66 2.58 5.26 4.73 3.86 4.12 3.73 3.48 
Tryptophan 205.0972 12.85 31.57 - - 11.34 - 20.42 - - 23.46 9.08 8.78 - - 
Tyrosine 182.0812 10.35 23.58 - -             - 1.57 1.79 - 
SAM 399.1445 19.60 23.25 - - 16.70 23.33 14.37 26.38 - - 15.82 23.06 18.66 3.93 
Thiamine 265.1118 15.46 - 13.76 -             18.27 26.13 - - 
Choline 104.1070 5.97 - 5.90 - 1.30 - -   6.30 6.18 5.19 5.52 2.53 1.71 
Acetyllysine 189.1234 9.69 - 12.91 - - - - - - - - - - - 
Urocanate 139.0502 7.37 - - 4.40 1.48 - - - - - 4.03 1.49 5.16 - 
Asparagine  133.0768 5.27 - - 59.99 5.98 7.13 5.62 3.90 - 6.03 - - - - 
Spermidine 146.1652 8.89 - - - 11.70 9.71 10.62 12.40 - - 9.46 - 9.70 - 
Putrescine  89.1073 4.50 - - - 1.92 - - - - - 5.95 - 22.30 - 
γ-aminobutyrate 104.0706 4.88 - - - 2.14 4.42 4.14 5.13 4.84 4.73 - - - - 
Guanine 152.0567 7.34 - - - 4.51 7.24 6.10 2.80 6.56 6.87 5.05 5.12 4.97 4.35 
Carnitine 162.1125 8.20 - - - 5.70 7.22 6.35 - - 6.29 2.90 3.92 - - 
Creatine  132.0768 5.60 - - - 3.78 2.97 3.91 3.93 3.46 3.61 3.37 3.37 2.53 2.57 
Argininosuccinate 291.1299 12.72 - - - 9.08 - - - - - 9.05 7.42 2.46 - 
Valine  118.0863 5.98 - - - 3.04 - 9.59 - - - 3.98 4.50 1.14 - 
Serine 106.0499 3.80 - - - 2.87 7.64 5.55 - 8.02 6.49 1.42 1.38 - - 
Threonine  120.0655 4.92 - - - 1.15 - 9.22 7.75 - - 1.12 2.00 1.47 2.21 
Methionine  150.0586 6.70             - - 13.29 8.14 7.59 - - 
Hypoxanthine  137.0458 7.00 - - - 4.72 7.36 5.85 
   
4.54 4.64 2.18 - 
Proline 116.0706 5.96 - - - 6.08 - 5.11 - 3.85 4.77 4.31 4.98 3.30 1.72 
Ser-Val 205.1183 9.73 - - - 11.12 - 2.24 - - - 14.30 14.86 16.64 21.28 
Aspartate 134.0448 4.93 - - - 2.37 - 3.19 - - 3.71 3.78 3.70 3.02 2.50 
Glutathione, 
oxidized 
307.0833 14.73 - - - 19.18 - 16.43 - - - 17.02 21.96 - - 
Glutathione 309.0911 13.13 - - - 12.70 - 4.89 - - 0.28 11.29 11.37 11.77 - 
Acetylcholine  146.1176 8.22 - - - - 17.88 - - - - 5.16 5.89 5.10 2.64 
Phenylalanine  166.0863 10.30 - - - - - - - - - 6.23 6.16 1.39 - 
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Metabolite  m/z 
Theor. 
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Thiamine  265.1118 15.46 10.68 - -         
  
29.15 12.54 43.48 
Spermidine 146.1652 8.89 12.72 5.08 - - 8.57 10.86 6.59 - 8.22 10.22 - - 
Putrescine 89.1073 4.50 
   
2.34 - - 2.12 - - 5.76 - 4.48 
Lysine 147.1128 7.50 6.46 7.40 6.81 6.26 6.11 6.44 5.84 7.55 6.91 6.40 5.92 6.42 
Arginine  175.1190 8.20 7.92 7.86 12.13 6.68 7.11 7.25 8.41 9.59 4.74 6.45 6.78 6.52 
Guanine 152.0567 7.30 0.51 4.31 - 5.10 5.87 6.14 20.51 8.75 2.13 5.01 5.04 4.88 
Carnitine 162.1125 8.20 4.88 - 10.43 6.57 6.95 7.48 6.91 - 0.39 5.63 6.63 - 
Acetylcarnitine 204.1230 10.50 6.76 5.79   7.81 10.84 10.62 16.67 13.36 3.99 8.05 6.98 7.63 
Glutamine 147.0764 6.30 6.90 4.17 6.43 5.44 5.04 5.10 5.50 5.94 5.67 5.06 5.62 5.34 
Glutamate 148.0604 6.00 3.20 - 10.46 4.39 4.33 4.11 5.68 - 3.26 4.75 4.88 3.87 
Ser-Val  205.1183 9.73 37.59 - - 10.50 - - - 3.01 - 11.62 12.16 14.73 
Choline  104.1070 5.97 - 5.69 - 5.93 - - - - 1.96 5.37 5.82 1.80 
Ornithine  133.0972 6.36 - 2.90 - 4.40 9.45 - - - 18.88 4.70 - - 
Urocanate 139.0502 7.37 - 3.77 -       - - - 2.09 - - 
Tryptophan 205.1183 12.85 - 19.01 - 9.80 22.77 20.32 - - - 9.29 17.28 - 
γ-aminobutyrate 104.0706 4.88 - - 5.37 - 4.65 4.39 4.13 4.82 - 0.32 - 0.22 
Serine 106.0499 3.82 - - 6.06 1.94 5.85 5.92 - - - 2.19 1.46 - 
Asparagine 133.0608 5.28 - - 11.81 8.00 6.61 6.36 3.99 4.08 3.56 4.02 6.18 - 
Threonine 120.0655 4.92 - - - 0.34 9.80 43.36 - - - 2.66 1.50 0.38 
Glutathione, oxidized 307.0833   - - - - - - - - - 16.87 1.58 20.06 
Glutathione 308.0911 13.14 - - 13.85 11.06 - - - - - 10.78 7.38 11.47 
SAM 399.1445 19.60 - - - 18.62 - 19.47 - - - 21.97 - 25.01 
Ser-Arg 262.1510 11.94 - - - 9.52 - - - - - 12.91 - - 
Acetylcholine 146.1176 8.19 - - - 5.49 - - - - - 5.91 4.74 4.82 
Methylaspartate 148.0604 6.04 - - - 2.61 - - - - - 0.49 3.09 - 
Creatine 132.0768 5.60 - - - 4.01 3.47 3.87 - - - 3.68 4.14 3.05 
Pro-Val 215.1390 11.87 - - - 9.62 - - - - - - 19.62 - 
Argininosuccinate 291.1299 12.72 - - - 12.16 - - - - - 12.73 4.92 16.44 
Valine 118.0863 5.98 - - - 4.09 8.54 - - - - 4.82 4.19 1.88 
Phenylalanine 166.0863 10.30 - - - 8.09 - 6.05 - - - 7.66 7.23 6.18 
Tyrosine 182.0812 10.35 - - - 7.67 - - - - - 4.49 6.78 - 
Proline 116.0706 5.96 - - - 3.71 4.62 - - - 13.29 4.88 4.22 3.06 
Aspartate 134.0448 4.93 - - - 3.57 3.17 4.00 - - - 3.75 3.82 3.51 
Isoleucine 132.1019 7.09 - - - - 15.00 12.3 - - - 4.82 1.90 0.60 
Leucine  132.1019 7.09 - - - - 11.23 10.5 - - - 4.90 - 2.57 
Hypoxanthine  137.0458 7.00 - - - - 5.80 5.91 - - - - 4.70 4.01 








































Spermidine 146.1652 8.89 7.52 8.75 8.89 10.70 16.53 7.91 6.68 16.89 9.79 8.79 8.44 7.84 4.93 
Putrescine  89.1073 4.50 3.81 - - - - 0.18 2.56 - - 5.31 5.57 5.74 5.91 
Thiamine 265.1118 15.46 - - - - - - 7.65 7.39 - 18.19 37.75 20.78 17.88 
Choline 104.1070 5.97 4.89 - - - - 2.00 1.64 2.26 5.91 5.51 6.33 2.56 4.59 
SAM 399.1445 19.60 32.02 - - 18.03 - 27.21 44.83 - - 19.33 23.72 16.90 22.14 
Ornithine  133.0972 6.36 6.31 - - 10.01 - - - - - 6.15 6.29 6.88 9.05 
Lysine 147.1128 7.47 6.24 6.22 7.36 6.50 7.66 7.16 17.53 5.53 8.81 5.99 6.49 6.58 6.33 
Arginine 175.1190 8.16 6.41 7.39 8.26 7.31 3.29 5.29 5.83 5.63 5.86 6.32 6.07 6.33 6.83 
γ-aminobutyrate 104.0706 4.88 0.85 - 4.85 3.92 - - 6.04 6.20 6.36 0.29 0.46 - - 
Acetylcholine  146.1176 8.19 0.97 - -       2.76 1.88 7.69 4.90 4.41 4.69 5.62 
Guanine 152.0567 7.30 0.46 - 7.13 6.29 1.88 1.20 3.53 4.25 6.22 4.68 4.80 4.89 5.10 
Carnitine 162.1125 8.20 3.18 4.50 10.24 9.42 - - 6.63 5.60 12.98 5.38 - - 3.15 
Acetylcarnitine  204.1230 10.50 7.50 8.35 15.90 14.11 - 0.96 3.90 3.74 3.90 6.67 6.35 7.29 7.21 
Creatine  132.0768 5.60 3.79 4.45 - 3.31 - - 1.22 1.17 - 3.45 3.58 3.28 3.57 
Valine 118.0863 5.98 1.40 - - 16.08 - 2.95 7.32 8.76 7.19 3.38 3.21 1.30 3.61 
Serine 106.0499 3.80 1.64 - -       13.01 11.02 - 1.32 - 0.93 0.97 
Isoleucine 132.1019 7.02 0.28 - -       21.66 20.11 18.88 3.74 4.27 3.09 3.33 
Leucine 132.1019 7.02 0.56 - -       6.09 6.10 100.17 4.06 4.03 3.17 3.66 
Asparagine 133.0608 5.27 8.18 - - - - 5.44 4.93 5.87 118.97 1.88 0.98 - - 
Tryptophan 205.0972 12.85 14.94 - - 21.22 - - 7.09 7.46 5.12 8.44 8.61 74.63 - 
Glutamine  147.0764 6.30 5.54 5.79 6.22 5.34 8.91 7.04 - 0.75 3.86 5.10 4.99 5.41 5.46 
Glutamate  148.0604 6.00 3.21 2.97 - 4.34 1.82 2.97 - - 5.73 4.34 4.35 3.96 4.06 
Hypoxanthine  137.0458 7.00 3.59 3.78 6.55 6.17 - 4.03 - - 7.37 4.51 4.15 4.08 4.37 
Glutathione, ox. 307.0833 26.24 18.80 22.38 21.37 - - - - - 5.69 - 18.64 4.27 
 
Glutathione 308.0911 13.13 - 22.13 14.92 - - - - - - 10.80 10.18 9.66 11.22 
Proline 116.0706 5.96 - - - - - - - - - 3.49 3.35 3.26 4.59 
Ser-Val 205.1183 9.73 - - - - - - - - - 13.23 13.17 14.46 17.13 
Aspartate 134.0448 4.93 - - - - - - - - - 2.99 2.84 2.93 3.46 
Arg-Ala  246.1561 11.90 - - - - - - - - - 9.50 14.25 27.26 20.74 
Ser-Arg 262.151 11.94 - - - - - - - - - 12.31 11.03 16.44 16.56 
Homolysine 161.1285 8.57 - - - - - - - - - 26.79 25.70 - - 
Argininosuccinate 291.1299 12.72 - - - - - - - - - 15.02 6.67 19.97 4.63 
Methionine 150.0583 6.77 - - - - - - - - - 5.53 2.88 - 5.30 
Phenylalanine 166.0863 10.30 - - - - - - - - - 7.38 6.08 5.08 4.10 
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Spermidine 146.1652 8.89 7.68 7.64 9.26 12.41 8.17 9.34 7.38 7.71 2.73 8.89 8.55 7.89 
Putrescine  89.1073 4.50 4.04 3.06 - - 1.09 1.61 - - 1.60 5.53 5.92 5.27 
Thiamine 265.1118 5.97 - - - - - - 8.53 8.50 4.26 22.10 40.31 156.69 
SAM 399.1445 19.60 22.83 29.88 - 18.75 11.38 35.60 44.59 54.66 - 14.76 29.46 33.60 
Ornithine  133.0972 6.36 5.90 8.27 - 9.34 9.33 - 16.33 21.24 18.65 8.78 8.45 4.99 
Lysine  147.1128 7.50 6.36 6.36 6.32 6.19 6.13 7.03 5.92 6.20 6.57 6.44 6.20 6.59 
Arginine  175.119 8.20 6.80 6.68 7.17 6.89 7.19 5.80 5.81 5.50 5.06 6.85 6.36 8.22 
Homolysine  161.1285 8.57 10.51 - - - - - - - - - - - 
γ-aminobutyrate 104.0706 4.88 2.37 1.76 4.86 4.34 4.05 0.19 - - 0.37 0.25 - - 
Guanine 152.0567 7.30 4.03 - 6.24 8.58 - 0.41 2.17 2.11 3.01 4.83 4.53 4.57 
Carnitine 162.1125 8.20 5.51 3.97 8.25 7.47 - 4.79 2.62 7.26 3.82 6.93 7.28 4.75 
Acetylcarnitine  204.123 10.50 7.27 4.48 11.97 13.47 14.39 2.72 6.35 4.08 7.42 3.09 2.96 4.17 
Creatine  132.0768 5.60 4.14 4.23 - - - - 3.94 3.80 4.04 - - - 
Serine 106.0499 3.80 2.26 2.20 - 8.37 6.65 8.33 1.04 0.65 1.46 - 0.30 - 
Valine  118.0863 5.98 - - - 15.23 - 4.83 - - - 3.20 1.18 1.99 
Asparagine  133.0608 5.27 5.55 - 9.83 - - - 7.04 10.01 10.42 - - - 
Tryptophan 205.0972 12.85 56.95 - - - - - 12.48 - 55.63 - - - 
Methionine  150.0583 6.70     - - - - 16.83 6.62 22.85 - - - 
Glutamine  147.0764 6.30 5.47 5.62 5.46 5.40 5.37 5.70 6.29 5.69 6.49 5.73 5.18 5.58 
Glutamate  148.0604 6.00 4.06 2.32 6.66 5.05 4.64 2.40 4.42 5.06 5.44 3.76 3.69 3.10 
Phenylalanine  166.0863 10.30 7.26 - -       - - 2.45 5.09 1.72 3.83 
Hypoxanthine  137.0458 7.00 5.15 3.31 6.21 7.79 7.97 3.44 - - - 4.01 0.64 1.58 
Proline  116.0706 5.96 11.73 - 10.24 - 4.92 19.12 7.62 7.99 9.92 4.42 1.63 - 
Glutathione, oxidized 307.0833 14.73 21.65 - - - - - 21.03 - - 12.74 - - 
Glutathione 308.0911 13.13 11.56 - 12.82 - - - - - - 10.90 11.24 13.23 
Choline 104.1070 5.97 3.62 - - - - - 3.52 1.93 1.73 5.59 4.58 4.89 
Guanidinopropanoate 132.0768 5.61 - - 3.94 - - - - - - - - - 
Ser-Val 205.1183 9.73 - - 14.14 - - - - - - 27.13 - - 
Ser-Arg 262.151 11.94 - - - - - - - 7.42 - 15.99 14.44 9.55 
Ala-Lys 218.1499 11.17 - - - - - - - - - 6.87 6.35 - 






Appendix 4.3 KEGG pathway analysis (statistical p-value and pathway impact) of dorsal and ventral clones of the X. laevis embryo (see 
plot in Figure 4.3). Key: Thr*, 13C4,15N-L-threonine; Met*,13C5,15N-L-methionine. 
 
Dorsal clone with Thr* 
     
Dorsal clones with Thr* and Met 
    
Label  Name of metabolic pathway Total Hits p Impact Label  Name of metabolic pathway Total Hits p Impact 
1 Arginine and proline  43 4 1.69E-04 0.25 1 Aminoacyl-tRNA biosynthesis 67 9 2.03E-08 0.10 
2 Glutathione  26 3 7.14E-04 0.05 2 Valine,leucine,isoleucine  13 4 1.19E-05 1.00 
3 Aminoacyl-tRNA biosynthesis 67 4 9.59E-04 0.10 3 Arginine and proline  43 4 1.62E-03 0.24 
4 Alanine,aspartate,glutamate  24 2 1.27E-02 0.11 4 Glutathione  26 3 3.69E-03 0.05 
5 Cysteine and methionine  29 2 1.83E-02 0.06 5 Valine,leucine,isoleucine  38 3 1.09E-02 0 
6 Cyanoamino acid  6 1 4.41E-02 0 6 Alanine,aspartate,glutamate  24 2 3.55E-02 0.15 
7 Methane  9 1 6.54E-02 0.40 7 Cysteine and methionine  29 2 5.04E-02 0.06 
8 β-Alanine  16 1 1.14E-01 0 8 Glycine,serine and threonine  31 2 5.69E-02 0.26 
9 Sphingolipid  21 1 1.47E-01 0 9 D-Glutamine and D-glutamate  5 1 6.20E-02 0 
10 Butanoate  22 1 1.53E-01 0.03 10 Cyanoamino acid  6 1 7.39E-02 0 
11 Glycine,serine and threonine  31 1 2.09E-01 0.23 11 Nitrogen  9 1 1.09E-01 0 
12 Tryptophan  39 1 2.57E-01 0.15 12 Methane  9 1 1.09E-01 0.4  
Ventral clone with Met* 
     
Ventral clone with Met* and Thr 
    
Label  Name of metabolic pathway Total Hits p Impact Label  Name of metabolic pathway Total Hits p Impact 
1 Aminoacyl-tRNA biosynthesis 67 8 1.26E-07 0.10 1 Glutathione  26 4 3.37E-05 0.06 
2 Arginine and proline  43 6 3.10E-06 0.33 2 Arginine and proline 43 4 2.59E-04 0.30 
3 Alanine, aspartate, glutamate  24 3 2.00E-03 0.31 3 Aminoacyl-tRNA biosynthesis 67 3 1.48E-02 0 
4 Cysteine and methionine 29 3 3.49E-03 0.17 4 Alanine,aspartate, glutamate  24 2 1.54E-02 0.02 
5 Glycine, serine and threonine  31 3 4.24E-03 0.26 5 Cysteine and methionine  29 2 2.21E-02 0.17 
6 β-Alanine  16 2 1.28E-02 0 6 Thiamine metabolism 7 1 5.62E-02 0.40 
7 Glutathione  26 2 3.26E-02 0.01 7 β-Alanine  16 1 1.24E-01 0 
8 Cyanoamino acid  6 1 6.55E-02 0 8 Tryptophan  39 1 2.78E-01 0.15 
9 Methane  9 1 9.67E-02 0.40   
    
  
10 Valine,leucine,isoleucine  13 1 1.37E-01 0   
    
  
11 Histidine 14 1 1.47E-01 0   
    
  




















Spermidine (SPM)** C7H19N3 10.34 146.1654 146.1652 –0.2 –1.4 
Putrescine‡ C4H12N2 10.92 89.1073 89.1073 0.0 0.0 
Methylhistamine** C6H11N3 11.43 126.1019 126.1026 0.7 5.6 
Thiamine** C12H16N4OS 12.02 265.1117 265.1118 0.1 0.2 
Choline (Cho)*,** C5H13NO 16.51 104.1065 104.1070 0.5 4.8 
Ala-Lys (AK)** C9H19N3O3 16.74 218.1492 218.1491 –0.1 –0.5 
Arg-Ala (RA) ** C9H19N5O3 17.08 246.1557 246.1561 0.4 1.5 
Lys-Ser (KS)** C9H19N3O4 17.15 234.1449 234.1448 –0.1 –0.3 
Val-Lys (VK) ** C11H23N3O3 17.49 246.1820 246.1812 –0.8 –3.2 
S-adenosyl-methionine 
(SAM)** C15H22N6O5S 17.44 399.1461 399.1445 –1.6 –4.0 
Ser-Arg (SR)** C9H19N5O4 17.49 262.1516 262.1510 –0.6 –2.3 
Ornithine (Orn) ** C5H12N2O2 17.7 133.0969 133.0972 0.3 2.3 
Sarcosine‡ C3H7NO2 17.87 90.0557 90.0550 –0.7 –7.8 
Lysine (Lys)*,** C6H14N2O2 17.88 147.1131 147.1128 –0.3 –2.0 
Arginine (Arg) *,** C6H14N4O2 18.45 175.1193 175.1190 –0.3 –2.0 
Homolysine** C7H16N2O2 18.47 161.1295 161.1285 –1.0 –6.5 
Tyr-Lys (YK)** C15H23N3O4 18.55 310.1757 310.1761 0.4 1.4 
γ-aminobutyric acid 
(GABA) C4H9NO2 18.67 104.0701 104.0706 0.5 4.9 
N6,N6,N6-trimethyl-
lysine (TML) ** C9H20N2O2 18.71 189.1599 189.1598 –0.1 –0.8 
Histidine (His)*,** C6H9N3O2 18.74 156.0775 156.0768 –0.7 –4.8 
Methylhistidine**  C7H11N3O2 19.23 170.0945 170.0924 –2.1 –12.3 
Guanidinopropanoate** C4H9N3O2 19.47 132.0766 132.0768 0.2 1.2 
Acetylcholine 
(AcCho)*,** C7H15NO2 19.7 146.1176 146.1176 0.0 –0.3 
Trolamine (TEA)‡ C6H15NO3 20.01 150.1123 150.1125 0.2 1.3 
Leu-Ala (LA)** C9H18N2O3 20.1 203.1381 203.1390 0.9 4.5 
Cis-urocanate (cURA)** C6H6N2O2 20.22 139.0495 139.0502 0.7 5.0 

















Carnitine (Car) *,**  C7H15NO3 20.85 162.1133 162.1125 –0.8 –5.1 
Trans-Urocanate** C6H6N2O2 20.99 139.0495 139.0502 0.7 5.0 
Methylguanine** C6H7N5O 21.28 166.0722 166.0723 0.1 0.6 
Pyridoxal** C8H9NO3 21.43 168.0662 168.0655 –0.7 –4.0 
Cytosine** C4H5N3O 21.76 112.0496 112.0505 0.9 8.0 
Acetylcarnitine (AcCar)** C9H17NO4 22.44 204.1228 204.1230 0.2 1.1 
Propionylcarnitine** C10H19NO4 23.13 218.1386 218.1387 0.1 0.5 
Methylaspartate** C5H9NO4 23.2 148.0607 148.0604 –0.3 –1.8 
Glycine (Gly)* C2H5NO2 23.50 76.0386 76.0393 0.7 9.3 
Niacinamide* C6H6N2O 23.31 123.0547 123.0553 0.6 4.8 
Creatine (CR)*,** C4H9N3O2 23.53 132.0765 132.0768 0.3 1.9 
Pro-Val (PV)** C10H18N2O3 24.03 215.1386 215.1390 0.4 1.9 
Adenosine** C10H13N5O4 24.32 268.1049 268.1040 –0.9 –3.4 
Alanine (Ala)* C3H7NO2 23.53 90.0550 90.0550 0.0 –0.5 
Argininosuccinate 
(ASA)** 
C10H18N4O6 26.43 291.1310 291.1299 –1.1 –3.7 
Valine (Val)*,** C5H11NO2 28.54 118.0860 118.0863 0.3 2.2 
Serine (Ser)*,** C3H7NO3 28.59 106.0494 106.0499 0.5 4.4 
Isoleucine (Ile) *,‡ C6H13NO2 28.84 132.1015 132.1019 0.4 3.1 
Leucine (Leu) *,‡ C6H13NO2 29.1 132.1015 132.1019 0.4 3.1 
Asparagine (Asn)** C4H8N2O3 30.17 133.0607 133.0608 0.1 0.5 
Threonine (Thr)*,** C4H9NO3 30.2 120.0651 120.0655 0.4 3.5 
Tryptophan (Trp)*,** C11H12N2O2 30.76 205.0965 205.0972 0.7 3.2 
Methionine (Met)*,** C5H11NO2S 30.89 150.0586 150.0583 –0.3 –1.8 
Glutamine (Gln)*,** C5H10N2O3 30.96 147.0766 147.0764 –0.2 –1.2 
2-Aminoadipic acid** C6H11NO4 31.08 162.0768 162.0761 –0.7 –4.4 
Methylene glutamine**   C6H10N2O3 31.20 159.0769 159.0764 –0.5 –3.1 
Citrulline (Cit)** C6H13N3O3 31.39 176.1030 176.1030 0.0 –0.2 
Homocitrulline** C7H15N3O3 31.46 190.1171 190.1186 1.5 8.0 
Glutamic acid (Glu)*,** C5H9NO4 31.43 148.0605 148.0604 –0.1 –0.4 

















Acetyllysine‡ C8H16N2O3 32.33 189.1232 189.1234 0.2 0.9 
Tyrosine (Tyr)*,** C9H11NO3 32.41 182.0809 182.0812 0.3 1.5 
Hypoxanthine (HPX)*,** C5H4N4O 32.46 137.0458 137.0458 0.0 –0.1 
Proline (Pro)*,** C5H9NO2 32.98 116.0702 116.0706 0.4 3.5 
Ser-Val (SV)† C8H16N2O4 33.38 205.1180 205.1183 0.3 1.4 
Cysteine (Cys)*,** C3H7NO2S 33.5 122.0260 122.0270 1.0 8.4 
Aspartic acid (Asp)*,** C4H7NO4 34.6 134.0446 134.0448 0.2 1.4 
Glycine betaine (GB)*,‡ C5H11NO2 35.23 118.0857 118.0863 0.6 4.7 
Glutathione, oxidized  
(GSSG)** 
C20H32N6O12S
2 35.92 307.0848 307.0833 –1.5 –5.0 
Hydroxyproline (Hyp)** C5H9NO3 37.2 132.0648 132.0655 0.7 5.5 
Glutathione (GSH)*,** C10H17N3O6S 38.96 308.0924 308.0911 –1.3 –4.3 
 
Note: Asterisk (*) signifies identification based on migration-time comparison to chemical standards. 
Double asterisk (**) denotes identification by tandem mass spectrometry experiments on related 
standards or comparison to data available in Metlin (hppt://metlin.scripps.edu), MzCloud 
(hppt://mzcloud.org), or HMDB (hppt://hmdb.ca). Dagger (†) indicates that tandem mass spectrum 
agrees with molecular fragmentation predicted in Mass Frontier 7.0 (Thermo Fisher). Double dagger 






























Appendix 5.2 Results from GProX174 cluster analysis of average metabolite ratios 
between dorsal and ventral cells in the 16-cell X. laevis embryo. Unidentified 
molecular features are listed as accurate mass (m/z) values. 
 
Mol. Feature  Cluster D12/D11 V12/D11 V11/D11 
351.099 0 1.20 1.09 1.06 
Putrescine 0 0.87 0.86 0.90 
Choline 0 0.97 0.92 1.06 
SAM 0 0.89 0.82 0.93 
120.1022 0 0.99 1.47 1.22 
Guanine 0 0.96 0.91 1.26 
135.0287 0 0.94 0.80 1.30 
Carnitine 0 0.86 0.83 0.78 
150.0582 0 0.86 1.17 0.91 
166.107 0 0.92 1.20 1.15 
194.1533 0 0.88 0.80 1.28 
188.0705 0 0.92 0.92 1.14 
Phenylalanine 0 0.86 0.76 0.96 
Hypoxanthine 0 1.03 0.96 1.15 
255.0969 1 4.80 1.27 4.78 
138.1022 1 0.92 0.72 1.01 
152.118 1 0.94 0.56 0.75 
180.1492 1 0.84 0.69 0.91 
214.1332 1 1.12 0.59 0.95 
116.0705 1 0.85 0.50 0.76 
Ornithine 1 0.89 0.55 0.76 
Lysine 1 0.77 0.52 0.73 
Arginine 1 0.84 0.64 0.77 
Histidine 1 0.88 0.60 0.96 
232.9989 1 0.46 0.12 0.69 
192.1378 1 0.60 0.12 0.81 
278.1258 1 1.28 0.63 1.23 
Valine 1 0.84 0.61 0.81 
Isoleucine 1 0.98 0.52 0.83 
Leucine 1 0.84 0.67 0.86 
Threonine 1 0.87 0.55 0.78 
159.0767 1 0.73 0.53 0.76 
176.1032 1 0.86 0.63 0.95 
Glutamate 1 0.91 0.64 0.82 






Mol. Feature  Cluster D12/D11 V12/D11 V11/D11 
Aspartate 1 0.91 0.66 0.88 
Hydroxyproline 1 0.86 0.67 0.83 
Glutathione 1 0.98 0.71 0.99 
290.8472 2 0.96 0.71 0.43 
GABA 2 134.35 0.56 0.60 
TML 2 0.76 0.64 0.73 
124.1118 2 0.90 0.37 0.14 
Acetylcholine 2 0.83 0.77 0.73 
144.1377 2 0.14 0.11 0.17 
Methyl guanine 2 1.84 0.71 0.90 
204.1233 2 0.84 0.66 0.75 
144.1019 2 0.18 0.00 0.08 
112.0499 2 1.06 0.78 0.59 
198.1846 2 0.78 0.56 0.56 
240.1226 2 0.73 0.18 0.32 
Creatine  2 0.68 0.75 0.66 
Methionine  2 0.85 0.71 0.66 
Aspartate 2 0.93 0.53 0.68 
Glutamate 2 0.82 0.54 0.68 
Proline 2 0.62 0.26 0.26 
Glycine betaine 2 0.81 0.61 0.62 
102.9699 3 1.60 2.56 3.09 
146.996 3 1.04 1.73 1.50 
197.0326 3 2.35 2.73 2.14 
218.9831 3 1.13 14.59 1.31 
232.9989 3 0.89 12.57 1.03 
119.0189 3 1.09 1.64 1.30 
133.0315 3 1.19 1.70 1.44 
101.0082 3 1.08 1.79 1.33 
218.9831 3 2.33 3.73 1.41 
135.0287 3 1.41 4.37 2.08 
182.9801 3 1.23 2.15 1.68 
246.1555 3 0.52 1.40 1.17 
Ser-Arg 3 0.50 1.41 1.06 
100.1119 3 2.58 3.00 1.61 
130.1583 3 1.31 2.19 2.30 
202.18 3 0.53 1.79 0.84 
246.242 3 1.71 2.41 1.97 






Mol. Feature  Cluster D12/D11 V12/D11 V11/D11 
338.1818 4 0.65 0.69 0.82 
142.1226 4 0.73 0.66 0.92 
150.1125 4 1.76 1.65 6.87 
254.0191 4 0.51 0.78 1.54 
210.1488 4 0.55 0.73 0.80 
255.0969 4 0.76 0.66 0.98 
134.0807 4 0.57 0.69 0.82 
212.201 4 0.61 0.80 0.82 
Serine  4 0.92 0.69 1.14 
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